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Abstract
The neurological influence of ischemic stroke in the initiation and perpetuation of strokeinduced heart injury (SIHI) has been acknowledged for several years. However, an underlying
pathophysiological mechanism remains uncertain. Clinically, it is hypothesized that stroke
involving the insular cortex (IC) initiates SIHI; since the IC controls autonomic regulation of
cardiovascular function. Yet, given the high prevalence of shared risk factors between ischemic
stroke and cardiovascular disorders, mechanistic conclusions from clinical studies are largely
speculative. We therefore sought to establish a novel rodent model of focal insular ischemic
stroke, used to evaluate potential behavioural and pathological outcomes of SIHI. Focal
ischemic stroke was induced into the right or left IC of 6-month-old male Wistar rats, through
stereotaxic injection of endothelin-1 (ET-1). Control groups received an injection of ibotenic
acid (IA), phosphate-buffered saline (PBS) or no injection (NI). Before euthanasia, rats were
assessed for autonomic deficits in sensorimotor gating. At 28 days post-injection, rats with left
IC damage displayed an overall trend of deficiencies in sensorimotor gating; compared to rats
with right IC damage and PBS/NI control groups. Pathologically, all injured groups (IA/ET-1)
exhibited a chronic increase in microglia activation, present at the IC and remote white/grey
matter regions. Furthermore, these groups expressed cardiac fibrosis within the left atrium.
When correlated, a positive association between microglia activation and cardiac fibrosis was
observed. With this novel model, we have successfully identified several downstream
consequences of IC stroke within the brain and heart, affirming the focal contribution of IC
damage to SIHI. Taken together, these preliminary results provide important insight into
potential mechanisms of post-stroke cardiac damage, serving as future therapeutic targets for
SIHI.
Keywords: ischemic stroke, stroke-induced heart injury, insular cortex, autonomic
dysfunction, neuroinflammation
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Section 1: INTRODUCTION

1

1.1 The Brain-Heart Connection
Acknowledgement and identification of the brain-heart connection was first reported
in 1942 by Walter B. Cannon, in his paper entitled “Voodoo Death.” Here, Cannon recounted
early incidents of sudden death from fright, hypothesizing the innate capability of the nervous
system to injure the heart 1. Since then, numerous neurological disorders have been associated
with adverse cardiovascular events 2. Among these, stroke stands out; contributing to a highfrequency of neurocardiac arrhythmias and lesions 3–6. While it has been speculated that insular
cortex damage, and arising autonomic dysfunction, contribute to this observed brain-heart
phenomenon 7, little is known about the underlying pathophysiology; making this intricate
relationship between the brain and heart a clinically relevant topic of interest.
1.2 Stroke
1.2.1 Stroke epidemiology and societal implications
Stroke is a global burden, negatively impacting the health and wellbeing of individuals
worldwide 8. In industrialized countries like Canada, stroke is the most common cause of
morbidity and a prominent source of mortality; only second to heart disease 9. As such,
numerous research efforts have been dedicated to the investigation of stroke occurrence and
prevention; resulting in the identification of key risk factors. In particular, high blood pressure,
diabetes, smoking, heart disease and age have all been recognized as major contributors of
stroke

10–15

. While increased knowledge and public awareness of these risk factors have

produced a recent North American decline in stroke occurrence 16, age remains a dominant and
uncontrollable risk factor. With the current ageing population, stroke incidence among the
elderly is expected to rise, significantly increasing stroke-related socioeconomic and healthcare
demands 9,17.
1.2.2 Stroke subtypes
Traditionally, stroke has been generalized into two basic categories: hemorrhagic and
ischemic. Hemorrhagic strokes are the less frequent subtype, accounting for approximately 1015% of all strokes 18. Manifestation of these strokes occur following the rupture of a cranial
blood vessel, an associated outcome of chronic hypertension 19–21. Consequently, this bleeding
within the brain increases intracranial pressure, further causing reduced blood flow to
surrounding tissue; ultimately expanding the region of hemorrhagic brain damage 22.
2

Ischemic strokes are typically less severe than hemorrhagic strokes, but much more
common – accounting for approximately 85-90% of all strokes 18. Due to this greater incidence
of ischemic strokes, our research will specifically study ischemic-induced cardiovascular
changes, despite a similar prevalence in both subgroups 6.
Mechanistically, ischemic strokes occur following the occlusion of a cranial blood
vessel, which inhibits local blood flow

23

. Numerous factors can contribute to this physical

blockade, including narrowing of the vessel wall (as observed in atherosclerosis) or the
presence of a blood clot 23. In some circumstances, a temporary blockage of short duration can
occur, generating a transient ischemic attack (TIA) 24. While the accompanying symptoms and
damage associated with TIAs are minimal, the occurrence of these “mini-strokes” are known
to increase the risk of a future ischemic episode 24–26.
1.2.3 Ischemic stroke interventions
Presently, intravenous administration of recombinant tissue plasminogen activator
(rtPA) serves as the only viable treatment for acute ischemic stroke

27,28

. This protein acts to

dissolve the intraluminal clotted material, restoring blood flow to the ischemic region

28

.

However, the therapeutic window for this drug is limited, requiring administration within 4.5
hours of occlusion onset

28,29

. According to epidemiological reports, less than 10% of the

eligible stroke population receives rtPA

30–32

; indicating a strong need for alternative stroke

therapies.
1.2.4 Pathophysiology of ischemic stroke
The pathophysiological response that occurs following ischemic stroke is a complex
process. Upon vessel occlusion, nutrient transport is obstructed; depleting local brain tissue of
key metabolites, such as glucose 33–37. Consequently, cells are incapable of producing adenine
triphosphate (ATP), an energy storage molecule crucial for tissue cell survival

38

. In this

absence of ATP, an ischemic cascade is activated, initiating the response of several cellular
mechanisms 33–37.
An initial loss of blood perfusion, and subsequent energy reduction, impairs cellular
ionic homeostasis 33–37. In a normal functioning neuron, the influx of potassium (K+) ions and
efflux of sodium (Na+) and/or calcium (Ca2+) ions across the cell membrane is tightly regulated,
due to a neuron’s vital role in impulse transmission 39. However, in the absence of ATP, this
3

regulation is inhibited; allowing for the uncontrolled build-up of intracellular Na + and Ca2+ 33–
37

. Compensation for this increase in cellular Na+ stimulates the movement of water (H2O) into

the cell, causing cytotoxic edema 40,41. This further restricts cerebral blood flow in surrounding
areas, enlarging the infarct region 40.
In response to the overaccumulation of cellular Ca2+, excess glutamate
neurotransmitters are released at the neuronal synapse and bind to nearby glutamate receptors:
N-methyl-D-aspartate (NMDA) or α-amino-3-hydroxy-5-methyl-4-proprionate (AMPA) 42,43.
This further disrupts the ionic balance of neighbouring cells, initiating an excitotoxic cascade
44

. Additionally, this increased presence of cellular Ca2+ activates degradative enzymes and

reactive oxygen species (ROS) production; damaging key cellular components, like
mitochondria

33–37

. Consequently, injured mitochondria release apoptotic factors

45

, further

contributing to ischemic cell death.
Irreversible cell death is the end-product of ischemic stroke, beginning to occur within
minutes of occlusion 33–37. At the site of blockage, blood levels are reduced to approximately
10% of basal levels, causing severe brain tissue necrosis

46

. Over time, this region becomes

void of glial cells and neurons, resulting in an undesirable loss of brain function 33–37.
Adjacent to this core region exists a viable brain area comprised of vulnerable, but
potentially salvageable tissue; referred to as the ischemic penumbra

33

. Collateralization of

vessel circuitry provides alternative sources of blood supply to this ischemic region, recovering
blood flow to approximately 20-60% of basal levels 46. Due to the redeeming potential of this
region, the penumbra serves as an optimal target for future stroke interventions.
1.2.5 Rodent models of ischemic stroke
Currently, numerous animal models and techniques are available for the experimental
study of stroke

47–53

. However, selection of the appropriate model should be reflective of the

clinical research question, as origin, location and size can all change outcomes of human
ischemic stroke

53,54

. Rodents particularly function as an advantageous stroke model, due to

extensive knowledge of their neuroanatomy 55 and similarities with human cranial circulation
52

.
Traditionally, middle cerebral artery occlusion (MCAO) has served as a popular

technique for the induction of ischemic injury. In this method, an endovascular monofilament
is inserted into the cerebral vasculature of the rat, blocking the middle cerebral artery (MCA)
4

bifurcation 56. This ultimately impairs cerebral blood flow, generating rapid ischemia within
the cortex and subcortical brain regions 56.
While implementation of MCAO produces a consistent infarct region, resulting damage
is widespread and severe

56

. Alternatively, intracranial injection of the vasoconstrictor

endothelin-1 (ET-1) has been used to produce a more targeted area of focal ischemia

57–59

.

Following administration, ET-1 binds to endothelin receptors present on the endothelial cells
of blood vessels, inducing vasoconstriction

58

. Based upon previous MRI perfusion studies,

resulting ischemia lasts for approximately 1 h before reperfusion 57. Unlike MCAO, use of ET1 provides versatility of infarct size and location

54,57

. However, it is important to note that

application of this method causes invasive damage unrelated to ischemic stroke. Intracranial
insertion of the cannula disrupts the skull, blood-brain barrier (BBB) and secondary brain
regions 47,53,54; which must be taken into account when analyzing results. In the present study,
neurocardiac influences associated with insular injury will be examined, requiring the
production of focal damage. For this reason, the ET-1 ischemic stroke model will be used for
experiments outlined in this thesis.
1.3 Ischemic Stroke and Neuroinflammation
Inflammation is a vital mechanism of ischemic injury, largely modulated by microglia
and astrocytes – immune cells of the central nervous system (CNS)

35–37,53

. During ischemia,

these cells work to retain neuron health and homeostasis, through active participation in tissue
repair and regeneration. However, not all forms of cerebral inflammation appear to produce
beneficial effects. Recent literature has identified a co-existing and contradictory influence of
neuroinflammation, capable of enhancing peri-infarct damage 60.
In response to toxic stimuli released by injured neurons during the ischemic cascade,
resting astrocytes become activated; referred to as astrogliosis

61

. During acute recovery,

astrocytes function to encapsulate the infarcted region within a glial scar (comprised of
astrocytes and microglia) in an effort to contain and repair the damaged area

61,62

. Recent

reports suggest that astrocytes may also amplify the ischemic inflammatory response through
the release of pro-inflammatory cytokines, such as tumour necrosis factor alpha (TNFα) and
interleukin-1 beta (IL-1β) 63, but exact mechanisms remain unclear.
Similar to astrocytes, microglia become activated in response to noxious stimuli;
termed microgliosis

35–37,53

. Upon activation, microglia undergo morphological changes,
5

transitioning from a ramified to amoeboid appearance 64. Interestingly, activated microglia can
exhibit phenotypic and functional variance depending on the nature, strength and duration of
presenting stimuli 60,64. Currently, two activated microglia subtypes have been identified: M1
and M2

60

. M2 microglia are characteristically involved with anti-inflammatory efforts;

phagocytosing toxic debris, releasing anti-inflammatory cytokines, such as transforming
growth factor beta-1 (TGFβ), and promoting neurogenesis

60,65

. Often deemed “helpful”

microglia, this M2 subtype works to minimize ischemic damage 60. Contrarily, M1 microglia,
frequently referred to as the “harmful” subtype, display an enhanced pro-inflammatory
response 60. Activation of these microglia results in the release of numerous pro-inflammatory
compounds, including TNFα, IL-1β, matrix metalloproteinases (MMPs), ROS and nitric oxide
(NO) 60,65. The particular presence of MMPs results in disruption of the BBB, allowing for the
infiltration of peripheral leukocytes

64

. This ultimately exacerbates local damage, while

inducing systemic inflammation; contributing to further stimulation of the immune response.
Occurrence of this systemic response is evident in a stroke patient’s blood sample, displaying
increased levels of white blood cells and the inflammatory marker, C-reactive protein (CRP)
37,66

.
In a recent study by Hu and colleagues, expression profiles of M1/M2 polarization post-

ischemic stroke were outlined. Intriguingly, ischemic microglia activation displayed a
differential shift in subtype expression 67. Soon after ischemic injury, an increased presence of
M2 microglia was observed

67

. However, this M2 appearance remained transient, gradually

transitioning to M1 phenotypic-dominance at 7 days post-stroke; suggesting a causative role
of chronic inflammation in ischemic injury expansion 67.
1.4 Secondary Consequences of Ischemic Stroke
1.4.1 Ischemic stroke and white matter injury
Damaging effects of ischemia on local grey matter remains a primary focus of stroke
research. Yet, recent clinical imaging studies have reported persistent white matter
inflammation (WMI) in major fibre tracts following ischemic stroke; with continued presence
several months into the recovery period 68–71. Alarmingly, this clinical manifestation of white
matter pathology has been functionally implicated in post-stroke prognosis; associated with
worse outcomes of prolonged recovery

68,72,73

. As such, secondary presentation of ischemic

WMI should not be ignored.
6

In the healthy brain, white matter fibre tracts serve as an internal communication
network, transferring information between remote grey matter regions

66

. Macroscopically,

white matter consists of bundled axons, oligodendrocytes and astrocytes 66. Axons serve as the
central mechanism for action potential conduction, while also playing an important role in
nutrient/mediator transport between cell soma and synapse

66

. Oligodendrocytes are myelin-

producing cells responsible for axonal myelination 66,74; enhancing the accuracy and speed of
signal conduction 74. Astrocytes act to support oligodendrocyte and axonal health, influencing
myelination and maintaining homeostatic equilibrium

74

. Together, this white matter unit

functions to orchestrate rapid neuron-neuron communication

66,74

. Damage to any component

will perturb impulse signalling, causing detrimental sensory, motor and/or cognitive disruption
66,75

.
Similar to grey matter, white matter is critically dependent on a continuous supply of

oxygen and nutrients 66. However, unlike grey matter, white matter has a small blood supply
with limited collateral circulation; making it extremely susceptible to the toxic effects caused
by post-stroke ischemia
ischemia with age

76,77

66

. Additionally, white matter becomes increasingly susceptible to

, further stressing the powerful contribution of white matter injury to

overall ischemic damage. The pathophysiological cascade of white matter injury following
ischemic stroke is similar to that observed in grey matter. Depletion of local nutrients inhibits
oligodendrocyte and astrocyte cellular energy production, causing ionic dyshomeostasis

76

.

This increases extracellular glutamate and ATP, leading to excitotoxicity, oxidative stress and
initiation of the inflammatory response 76. Necrotic death of local oligodendrocytes ultimately
induces axonal demyelination and damage, impairing signal transduction 34. It is important to
note that the efficient conduction of an action potential through white matter circuitry requires
the persistent supply of energy along the entire length of the axon

66

. Consequently, local

reduction of blood flow at the occluded site can destroy the electrophysiological properties of
an entire axon, initiating delayed anterograde and/or retrograde secondary axonal degeneration
66,71

.

1.4.2 Ischemic stroke and neurodegeneration
Acute grey matter damage at the occlusion site, and within peri-infarct regions, is a
known consequence of ischemic stroke and an intense focus of pre-clinical neuroprotective
therapies

78,79

. However, recent clinical research has described a delayed occurrence of
7

secondary damage in remote brain regions

80–85

at chronic post-stroke timepoints

68,85

;

suggesting the existence of an ongoing or prolonged ischemic pathology. Neurologically, the
unfavourable manifestation of this remote injury has corresponded with adverse functional
deficits in ischemic stroke patients 68,72,73, commonly referred to as “diaschisis” 86.
Experimentally, several animal studies have observed a similar appearance of remote
neuronal loss post-ischemic stroke

87–91

. In particular, chronic pathology after MCAO in the

rat has consistently displayed secondary thalamic damage 87–90. More recently, Weishaupt and
colleagues reported ischemic neurodegeneration and neuronal loss within the retrosplenial
cortex of the rat, at 28 days following bilateral injection of ET-1 into the prefrontal cortex 91;
further supporting the aforementioned clinical findings.
Exact mechanisms of this delayed secondary pathology remain largely unknown and
may vary depending on the affected structures

91

. Yet, an intriguing commonality exists

between all observations of remote neuronal damage: location of the secondary degeneration
is dependent on anatomical connectivity to the primary infarct 87–91, suggesting a causative role
of the previously described white matter injury and axonal degeneration

92

. Presently, it is

hypothesized that following ischemic stroke, axonal degeneration of local inhibitory
GABAergic neurons prompts a loss of disinhibition to distant brain regions

90,92

. Inevitably,

this fosters an excitotoxic response, evoking neuronal cell death in these secondary areas 90,92.
A corresponding activation of local inflammatory mechanisms, in particular M1 microglia,
further enhances necrotic damage, contributing to ongoing chronic neurodegeneration 90,92.
While the exacerbated presence of secondary inflammation and neurodegeneration is
not ideal, the delayed nature of its pathology may widen the therapeutic window for stroke
intervention

91

. As such, future use of anti-inflammatory agents post-ischemic stroke could

serve to minimize associated functional deficits of secondary damage, ultimately improving
recovery time.
1.4.3 Ischemic stroke and heart injury
Adverse consequences of stroke are not limited to the brain. In fact, extensive clinical
and experimental research has demonstrated that damage incurred by stroke can extend to the
heart, causing structural and functional impairments

93–102

; referred to as stroke-induced heart

injury (SIHI). Initial reports of SIHI date back to the early 1950s, when Burch and colleagues
first identified electrocardiogram (ECG) abnormalities in hemorrhagic stroke patients 101. Soon
8

after, Koskelo and colleagues reported post-mortem presentation of subendocardial
hemorrhages in patients previously displaying stroke-induced ECG changes

100

. Further

supporting these clinical results, Burch and colleagues were first to confirm the histological
presence of stroke-induced myocardial lesions in a mouse model of hemorrhagic stroke

98

.

Since then, several animal models of hemorrhagic stroke have reproduced similar arrhythmias
and/or myocardial lesions 95,96,97,99.
While early research efforts largely concentrated on hemorrhagic SIHI, similar cardiac
outcomes have been observed in ischemic stroke patients

102–104

. As mentioned previously,

ischemic stroke accounts for roughly 85-90% of all strokes

18

, making this specific

neurocardiac relationship a great concern. Of particular attention, is the observed contribution
of ischemic stroke to the development of atrial fibrillation (AF)
arrythmia known to increase the risk of stroke 5-fold

15

102

. Currently, approximately 25% of

ischemic stroke patients display post-stroke cardiac episodes of AF
underpinnings remain unknown

105

. AF is a form of cardiac
102

; and yet, pathological

. Furthermore, 20-60% of ischemic stroke patients exhibit

elevated serum cardiac troponin T (cTnT) levels post-stroke, a known biomarker of myocardial
injury

104

. In a recent report by Wrigley and colleagues, this increased presence of cTnT

appeared to enhance the long-term risk for death after ischemic stroke 104; implying a capable
manifestation of acute SIHI into chronic, deadly outcomes.
1.5 Mechanisms of Stroke-Induced Heart Injury
1.5.1 The autonomic nervous system
To date, precise mechanisms of SIHI remain unclear, however, longstanding evidence
suggests a significant role of autonomic dysfunction

93,97

. The autonomic nervous system

(ANS) is a critical component of the peripheral nervous system (PNS), responsible for the
maintenance of internal homeostasis 106,107. Traditionally, the ANS has been separated into two
antagonistic divisions: the sympathetic nervous system (SNS) and the parasympathetic nervous
system (PSNS)

106,107

. Together, these two autonomic branches act to unconsciously regulate

visceral organ function, including cardiac activity

106,107

. A dysfunction in one system often

leads to adverse changes in the other, resulting in undesirable physiological consequences 2.

9

1.5.2 Neural control of cardiovascular function
Predominant modulation of autonomic cardiovascular function occurs through an
expansive network of cortical and subcortical brain regions 2,108–111. Together, these areas alter
sympathetic and parasympathetic outflow, initiating a change in cardiac activity

2

.

Physiologically, the successful mediation of this neural control requires efficient afferent and
efferent communication between the brain and heart 108.
Afferent cardiac signal transduction depends on the internal surveillance of
cardiovascular mechanical and chemical receptors

106,107,112

. Upon activation, these sensory

receptors will excite intrinsic cardiac neurons, initiating signal propagation

106,107,112

. Within

this autonomic circuitry, the brainstem acts as a vital communication link, relaying sensory
information from the periphery to upper forebrain regions

2,108

. As such, the nucleus of the

solitary tract (NTS), located within the medulla, serves as the first neural synaptic site of
afferent cardiac signals (Figure 1A) 2,108–110. From here, the signal is relayed to the parabrachial
nucleus (PbN) of the pons, prior to reaching the forebrain. Afferent projections from the PbN
directly synapse at the hypothalamus, amygdala, anterior cingulate cortex (ACC) and
prefrontal cortex (PFC)

108,109

; while the ventroposterior thalamus (VPT) serves as an

additional relay centre between the PbN and insular cortex (Figure 1A) 108. These cortical and
subcortical regions act as critical integration sites for autonomic cardiovascular function,
modulating cardiac activity in response to internal conditions 2,106,107,112.
Efferent alteration of heart function is directly mediated through sympathetic and
parasympathetic changes 2. Upon receipt of afferent cardiac information, the aforementioned
forebrain regions will alter efferent autonomic activity 108–110; evoking an increase or decrease
in cardiovascular function (Figure 1B)

106,107,112

. Increased cardiac activity requires enhanced

sympathetic output from cardiac nerves, initiated through the excitation of presympathetic
efferent neurons in the rostral ventrolateral medulla (RVLM) 2. Axons of the RVLM synapse
with preganglionic cholinergic sympathetic neurons in the spinal cord, which in turn, synapse
with postganglionic noradrenergic sympathetic neurons of cardiac stellate ganglia (Figure 1B)
2

. Excitation of these noradrenergic sympathetic neurons promotes the release of

norepinephrine (NE), a neurotransmitter capable of interacting with cardiac adrenergic
receptors; ultimately increasing heart function 106,107,112.
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Figure 1. Neural control of cardiovascular function. (A) Afferent pathway of autonomic
cardiovascular regulation. Brainstem cardiovascular sites (NTS/PbN) act as a vital relay centre
for the transmission of peripheral cardiac sensory information to regulatory forebrain regions
(PFC/ACC/HTH/AMYG/IC). The VPT serves as an additional autonomic relay centre
between the PbN and IC (region not shown). (B) Efferent pathway of autonomic cardiovascular
regulation. Autonomic modulation by PFC/ACC/HTH/AMYG/IC forebrain regions alters
sympathetic (RVLM) or parasympathetic (DMV/NA) output, generating an overall increase
(sympathetic) or decrease (parasympathetic) in heart rhythm. ACC = anterior cingulate cortex,
PFC = prefrontal cortex, VPT = ventroposterior thalamus, IC = insular cortex, HTH =
hypothalamus, AMYG = amygdala, PbN = parabrachial nucleus, DMV = dorsal motor nucleus
of the vagus, NA = nucleus ambiguus, NTS = nucleus of the solitary tract, RVLM = rostral
ventrolateral medulla. Adapted from Tahsili-Fahadan and Geocadin (2017) 2.
11

Not surprisingly, decreased cardiac activity requires enhanced parasympathetic output,
2

initiated through the vagus nerve

. Upon excitation, preganglionic cholinergic

parasympathetic neurons at the dorsal motor nucleus of the vagus (DMV) and/or nucleus
ambiguus (NA), both located within the medulla, will synapse with postganglionic cholinergic
parasympathetic neurons of efferent cardiac ganglia 2; releasing acetylcholine (ACh) (Figure
1B)

106,107,112

. In turn, this parasympathetic neurotransmitter binds to cardiac muscarinic

receptors, decreasing heart rate 106,107,112.
1.5.3 Increased sympathetic activity and stroke-induced heart injury
Early reports of SIHI have identified an accompanying increase in post-stroke
sympathetic activity 93–97. Yet, it remains unclear whether this enhanced sympathetic tone is a
direct effect of sympathetic upregulation, or indirect result of parasympathetic downregulation
104

. Regardless, this sympathetic hyperactivation increases NE release

106,107,112

, insinuating a

potential role of NE toxicity in the development of SIHI 2,93.
Mechanistically, NE stimulates the synthesis of adenylyl cyclase (AC), an important
regulator of myocardial Ca2+ channels

113

. In the presence of AC, Ca2+ channels will open,

initiating an influx of Ca2+ into local myocardiocytes 113. These elevated levels of Ca2+ enable
actin and myosin filaments to interact; an action necessary for cardiac muscle contraction 93,113.
Pathologically, prolonged exposure to NE will sustain channel opening and Ca 2+ availability,
permitting an unnatural period of continuous contraction 93,113. Consequently, myocardiocytes
will die, leading to irreversible structural cardiac damage and a corresponding alteration in
cardiac rhythm 2,93. Furthermore, the increased presence of cellular Ca2+ activates degradative
enzymes capable of injuring the subendocardial conductive network 2. This ultimately impedes
proper signal transduction, further disrupting normal heart rate and function 2,93.
1.5.4 Inflammation and stroke-induced heart injury
Recently, Olshansky hypothesized a regulatory role of the ANS in myocardial cytokine
production; similar to that observed in the spleen, liver and intestines

114

. Referred to as the

“inflammatory reflex” or “cholinergic anti-inflammatory pathway,” this neural regulation of
visceral inflammation is controlled by the vagus nerve 115. In short, the presence of peripheral
cytokines (TNFα, IL-1β) during an immune response will activate parasympathetic nerve
fibers, stimulating postganglionic release of ACh from visceral organs
12

106,107,112,114

. This ACh

can then enter immune cells through the α7nAChR nicotinic receptor, directly inhibiting
further transcription of proinflammatory cytokines; attenuating the inflammatory response
116,117
97

. As mentioned previously, sympathetic hyperactivation is a known outcome of stroke 93–

. Consequently, an associated decrease in parasympathetic tone could abolish beneficial

effects of the “inflammatory reflex,” perpetuating SIHI through enhanced cardiac and/or
systemic inflammation 105.
1.6 The Insular Cortex and Stroke-Induced Heart Injury
1.6.1 Insular cortex structure and function
The insular cortex (IC) is a highly-conserved, multimodal brain region, responsible for
a variety of cognitive functions

118–121

. In humans, the IC lies deep within the lateral sulcus,

beneath the frontal, parietal and temporal lobes 118. Traditionally, the IC has anatomically been
divided into an anterior and posterior region; with each extremity substantially differing in
connectivity to other brain structures

122

. As such, the IC remains heavily connected to an

expansive network of cortical and subcortical regions, serving as a vital sensorimotor
integration hub 118–120,122. To date, the IC has been implicated in an assortment of higher-order
functional tasks: ranging from sensory processing to representing feelings and emotions,
autonomic and motor control, risk prediction and decision-making, as well as complex social
functions – like empathy 118–123.
Recently, the pathophysiological relationship between IC damage and SIHI has gained
increased interest. As mentioned previously, the IC exerts autonomic control over
cardiovascular function, serving as an important forebrain site for the integration and alteration
of cardiac activity 2,108,109. It is therefore hypothesized that SIHI is a specific consequence of
insular ischemic stroke, with damage to the IC disrupting autonomic function; resulting in the
dysregulation of normal cardiac activity 123.
1.6.2 Clinical evidence of insular ischemic stroke-induced heart injury
Supporting this hypothesis, various clinical and epidemiological studies have discerned
an association between IC damage and SIHI

7,124–127

. Most recently, Gonzalez Toledo and

colleagues identified IC damage in 30.4% of ischemic stroke patients exhibiting atypical poststroke ECGs; compared to a 7.3% prevalence in patients with normal post-stroke cardiac
function 7. While these results suggest an increased risk of cardiac dysfunction following
13

insular ischemic stroke 7, it is important to note that preliminary mechanistic conclusions from
these clinical studies are largely speculative

105

. Given the high prevalence of shared risk

factors between ischemic stroke and cardiovascular disorders, it is clinically challenging in
these studies to confidently establish the neurological injury as the cause (or consequence) of
SIHI 2. Moreover, IC proximity to the MCA further complicates the pathophysiological
interpretation of current clinical findings. In the past, clinical studies of SIHI predominantly
recruited MCAO patients, due to the high incidence of this ischemic event. However, resulting
damage in this stroke region extends beyond the IC

56,120

; minimizing the specificity of

observed results. As such, experimental establishment of a focal insular ischemic stroke animal
model is critical for the elimination of these clinically-inevitable confounding variables.
1.6.3 Lateralization of insular autonomic function
Lateralization of insular autonomic function remains a current topic of discussion,
bound by contradicting clinical results
control over sympathetic activity
observations

128–130

127–132

127,131,132

. While early researchers identified right IC

, present studies have produced opposing

. Most recently, Krause and colleagues were able to temporally localize

autonomic lateralization to the anatomical subdivisions of the IC; discerning a right-sided
parasympathetic (and left-sided sympathetic) predominance in the posterior IC 130.
Intriguingly, current clinical reports have correlated right insular ischemic stroke to
worsened outcomes

125,133,134

. As such, it is theorized that ischemic damage to the right IC

inhibits parasympathetic control, shifting cardiovascular balance towards an increased
sympathetic tone 105,130; ultimately causing more severe outcomes of SIHI.
1.6.4 Rodent models of insular ischemic stroke
In 1989, Cechetto and colleagues were first to examine stroke-induced autonomic and
myocardial changes using a rodent model of MCAO; identifying an increase in blood pressure,
NE and myocardial damage 3 h after ischemic stroke

55

. Based upon these results, Cechetto

and colleagues concluded that their acute stroke model successfully mimicked clinical
observations of post-stroke autonomic dysfunction 55, further using it to examine lateralization
of IC autonomic control 135. Interestingly, this subsequent study identified the presentation of
severe sympathetic consequences following right MCAO

14

135

, implying a right-sided

parasympathetic dominance of IC lateralization in the rat. Yet, to our knowledge, additional
experimental studies have not been performed to validate this finding.
As mentioned previously, MCAO (within humans and rodents) creates a large infarct
region, extending beyond the IC

55,56,120

. As such, the isolated association of ischemic IC

damage with SIHI has yet to be confirmed. In 1995, Butcher and Cechetto reproduced similar
autonomic changes to those observed in their MCAO stroke model, following injection of the
excitotoxin D,L-homocysteic acid into the rat IC

136

. However, while this method produced

focal IC damage, the injury was not ischemic; limiting translational potential. With recent
advances in experimental stroke techniques 57–59, ET-1 can be used to establish a more focal,
and thus applicable, rodent model of insular ischemic stroke; confirming the mechanistic role
of IC damage in SIHI.
1.7 The Acoustic Startle Response
1.7.1 Circuitry of the acoustic startle response
In animals, including humans, the startle response is an autonomic reflex that serves to
protect the body 137–139. Following a sudden and intense stimulus, excitation of the startle reflex
will initiate rapid activation of cranial, facial and skeletal motor neurons; in preparation for
facilitation of a fight-or-flight reaction

138,139

. Initiation of the startle response can be evoked

through a variety of sensory signals; including acoustic, tactile, visual and vestibular stimuli
140

– of which the acoustic startle response (ASR) remains the most studied

139

. In humans,

behavioural observations of this ASR are predominantly measured through the eye-blink reflex
141,142

.
Mediation of the ASR occurs through a simple neural circuit in the lower brainstem

139,143,144

, consisting of three main synaptic sites: cochlear root neurons (CRNs), the caudal

pontine reticular nucleus (PnC) and facial motor neurons (Figure 2)

145,146

. In response to a

loud auditory stimulus, spiral ganglion cells of the cochlea will directly stimulate neighbouring
hair cells, transferring the sensory signal to CRNs of the auditory nerve

145

. From here, axons

of CRNs extend to the brainstem, synapsing with the cochlear nucleus (CN), which in turn,
synapses with the PnC

146,147

. The PnC serves as the indispensable sensorimotor interface of

the ASR 148–152. Upon receiving direct acoustic input from CN axons, giant neurons of the PnC
will project onto cranial, facial and skeletal neurons 152,153 to initiate a reflexive motor response
(Figure 2).
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Figure 2. Neural circuitry of the acoustic startle response. In response to a loud auditory
stimulus, spiral ganglion cells of the cochlea will stimulate cochlear hair cells; transferring the
sensory signal along the auditory nerve to the cochlear nucleus (CN) of the lower brainstem.
CN axons provide direct acoustic input to giant neurons of the caudal pontine reticular nucleus
(PnC). In turn, these giant neurons of the PnC directly synapse onto cranial, facial and skeletal
motor neurons, to initiate a rapid reflexive response. Adapted from Koch (1999) 139.
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1.7.2 Prepulse inhibition of the acoustic startle response
Enhancement or attenuation of the ASR can be modulated through a variety of
influences, including habituation 144,154,155, sensitization 144,156,157 and prepulse inhibition (PPI)
158,159

. In recent years, PPI of the ASR has received growing attention; serving as a reliable

measure of sensorimotor gating 139,160,161. Sensory gating is an autonomic process responsible
for the filtration of unnecessary or redundant external stimuli

160–162

. Proper function of this

gating system is imperative for efficient cognitive processing, minimizing overstimulation of
higher cortical brain regions 160,161.
PPI is the neurological phenomenon in which a weak prestimulus (prepulse) inhibits
the reaction to a subsequent strong, startling stimulus; attenuating normal ASR amplitude
(Figure 3A)
139,145,163

145,159

. Exact modulatory mechanisms of PPI on the ASR remain unknown

, however, present evidence suggests a direct inhibition of the PnC (Figure 3B)

148,152,164,165

. In response to an acoustic prepulse stimulus, CN axons will directly innervate the

inferior colliculus (IFC); a midbrain structure vital for acoustic PPI propagation

166–169

. From

here, the sensory signal is relayed to the superior colliculus (SPC) 170, which in turn, synapses
with the pedunculopontine tegmental nucleus (PPTg) 171–173. Anatomically, the PPTg contains
a descending cholinergic projection, directly extending to the PnC of the ASR pathway 174–176.
As such, stimulation of the PPTg initiates the release of ACh, inhibiting PnC excitation (Figure
3B) 174–176. Interestingly, ACh acts on the PnC through slow-responding muscarinic receptors,
eliciting a prolonged inhibitory effect

163,167

. Consequently, this long-lasting inhibition will

attenuate any subsequent startle responses occurring within 30-500 ms after prepulse
administration 163.
Currently, recognition of autonomic dysfunction within the rat is predominantly
classified through measurements of heart rate variability (HRV) or nerve discharge, requiring
the use of invasive experimental procedures

135,136

. However, Saitoh and colleagues have

reported a noradrenergic influence on PPI; observing deficits in sensorimotor gating following
blockage of this sympathetically-controlled hormonal system 177. As such, PPI of the ASR was
implemented in this thesis, to serve as an alternate (and less intrusive) behavioural
measurement of autonomic impairment.
1.7.3 Rodent models of the acoustic startle response
Recognition of the ASR in rats was first reported by Prosser and Hunter in 1936,
17

Figure 3. Schematic overview of PPI and associated neural circuitry. (A) Schematic
representation of PPI. Administration of a weak prestimulus (prepulse) inhibits the reaction to
a subsequent strong, startling stimulus; attenuating normal ASR amplitude. Adapted from
Koch and Schnitzler (1997) 145. (B) Neural circuitry of PPI. In response to an acoustic prepulse
stimulus, cochlear nucleus (CN) axons will directly innervate the inferior colliculus (IFC). The
sensory signal is then relayed to the superior colliculus (SPC), which in turn, synapses with the
pedunculopontine tegmental nucleus (PPTg). Stimulation of the PPTg initiates the release of
acetylcholine, ultimately inhibiting PnC excitation and attenuating the ASR. Adapted from
Fendt, Li and Yeomans (2001) 163.
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confirming identical elicitation and ASR patterns in both humans and rats

139,178

. Since then,

the rodent ASR has been extensively studied, in an attempt to better understand human
mechanisms of sensorimotor integration 139. In small animals, like the rat, measurements of the
ASR are recorded from a “whole body” reflex; analogous to the “eye-blink” reflex in humans
141,142,178

. The ASR becomes functional immediately after the onset of hearing, at

approximately postnatal day 12 in rats 179,180. Differences in strain, and individual variability,
can alter the magnitude of the ASR 181,182. However, this does not change the quality, or pattern,
of the reflex; simply causing an enhancement or attenuation of startle magnitude 145. As such,
the ASR in rodents serves as a reliable and robust measurement of sensorimotor integration
145

.
Similar to the ASR, identical mechanisms of PPI have been observed in humans and

rats 158,161,183. In both species, the amplitude of PPI remains dependent on the intensity of the
prepulse stimulus, as well as the time interval between presentation of the prepulse and
subsequent startle stimulus, referred to as the interstimulus interval (ISI)

163,184,185

. It is

important to note that due to the neural complexity of PPI mediation and modulation, certain
physiological manipulations may only affect PPI outcomes at a specific prepulse intensity or
ISI 184. As such, administration of assorted prepulse trials, varying in intensity (75 dB and 85
dB) and ISI (30 ms and 100 ms), is encouraged when assessing PPI of sensorimotor gating 184.
1.8 Rationale, Objective and Hypothesis
The neurological influence of ischemic stroke in the generation of SIHI has been
acknowledged for several years

2,93

. Yet, despite decades of research, the underlying

pathophysiology of this intricate brain-heart connection remains unknown. Past studies have
inferred a causative role of autonomic dysfunction in the manifestation of SIHI

93–97

.

Supporting this, recent clinical data has identified an enhanced prevalence of SIHI in patients
with damage to the IC
cardiovascular function

7,124–127

2,108,109

, a cortical site vital for the autonomic regulation of

. Intriguingly, these clinical studies have discerned worse

prognostic outcomes with right IC damage 125,133,134; implying a lateralization of IC autonomic
function. However, it is important to note that preliminary mechanistic conclusions from these
clinical studies are largely speculative

105

, given the high prevalence of shared risk factors

between ischemic stroke and cardiovascular disorders. As such, the establishment of a novel
focal insular ischemic stroke animal model is crucial to eliminate these clinically-inevitable
19

confounding variables, and affirm current pathophysiological predictions. Furthermore,
development of this novel rodent model will allow for the implementation of an accompanying,
non-invasive behaviour test; aimed to evaluate functional post-insular stroke autonomic
deficits. Successful application of this behavioural test could vitally improve current
knowledge of IC autonomic lateralization.
In 1989, Cechetto and colleagues successfully reproduced clinical outcomes of strokeinduced autonomic and myocardial damage, using a rat model of MCAO 55. However, use of
this technique creates a large infarct region, extending beyond the IC

55,56,120

. Consequently,

the isolated association of ischemic IC damage with SIHI has yet to be confirmed.
Additionally, due to the invasiveness and severity of the procedure 186, this experimental study
only assessed acute timepoints

55

. Therefore, to date, little is known about the long-term

prognosis and chronic effects of SIHI. Development of a focal insular stroke rodent model will
confine primary ischemic damage to the IC, and allow for the extended observation of chronic
pathology.
Recently, the contribution of inflammation, both cerebral and systemic, to SIHI has
gained increased interest 105,187,188. Pathologically, remote regions of neuroinflammation postischemic stroke have negatively corresponded to worse functional outcomes

68,72,73,86

. As

described previously, the IC belongs to an intricate network of cortical and subcortical
structures, responsible for the regulation of autonomic cardiovascular function

2,108,109,189

. As

such, histological identification of secondary neuroinflammation, in any of these forebrain
regions, could provide crucial insight into the neural manifestation of SIHI. Systemically, the
neuroinflammatory activation of M1 microglia has been known to disrupt the BBB, initiating
a peripheral immune response 64. Intriguingly, Olshansky has hypothesized a parasympathetic
role in the downregulation of myocardial inflammation 114. A decrease in parasympathetic tone
following IC damage could abolish beneficial effects of this PSNS regulation; enhancing
systemic influence on cardiac inflammation, and resulting SIHI 105; a mechanistic pathway yet
to be examined.
The brain-heart connection remains a relevant and fascinating area of research. While
past clinical, epidemiological and experimental studies have led to the identification and
classification of this complex phenomenon, questions of mechanistic contribution remain
unanswered. Successful establishment of a novel focal insular ischemic stroke rodent model

20

will allow for the extensive investigation of downstream behavioural and pathological
outcomes; enhancing current pathophysiological knowledge of SIHI.
Hypothesis: SIHI is the consequence of autonomic dysfunction and inflammation, specific to
insular ischemic stroke.
Objective: To establish a novel rodent model of focal insular ischemic stroke that can be used
to evaluate chronic downstream behavioural and pathological outcomes of the brain and heart;
improving mechanistic knowledge of SIHI.
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Section 2: METHODS
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2.1 Animals
Experimental animal procedures were performed in accordance with the Canadian
Council on Animal Care guidelines and approved by the Western University Animal Care
Committee (Protocol 2016-027; Appendix). Upon arrival, 54 six-month old male Wistar rats
(Charles River Laboratories, Montreal, QC), weighing 550-750 g, were individually housed at
Western University’s Animal Care and Veterinary Services on a 12:12 hour light/dark cycle
alternating at 1 AM/PM. Room temperature was maintained at 22-24°C, and all rats accessed
food and water ad libitum. Prior to surgical procedures, rats were randomly assigned to
experimental groups.
2.2 Rat Models
2.2.1 Endothelin-1 ischemic model
ET-1 is a potent vasoconstrictor frequently used in animal models to produce ischemic
strokes, similar to those observed in humans

57–59,190–192

. Focal injection of ET-1 inhibits

cerebral blood flow to the targeted brain region for approximately 1 h, prior to reperfusion 57.
To mimic ischemic stroke in our rodent model, human ET-1 (Lot E7764; Sigma-Aldrich,
Oakville, ON) was dissolved in sterile saline to achieve a final concentration of 20 pmol/µL.
Aliquots of 10 µL were stored at ‑80°C until required.
2.2.2 Ibotenic acid neurotoxic model
Although ET-1 is most representative of focal human ischemic stroke

191

, associated

ischemia can damage all structures located at the injection site; including intersecting white
matter fibers

190,193

. This makes it difficult to conclude whether observed behavioural and

pathological outcomes are a direct effect of targeted damage, or an indirect effect of unspecific
white matter injury. To overcome this confounding dilemma, administration of the neurotoxin
ibotenic acid (IA) was used as a positive control in this study; causing selective neuronal
damage within the IC 193,194. For this thesis, IA (Lot ab120041; Abcam Inc., Toronto, ON) was
dissolved in 0.1 M sterile phosphate-buffered saline (PBS) to achieve a final concentration of
5 µg/µL. Aliquots of 10 µL were stored at -80°C until required. An additional group of saline
control animals received administration of 0.1 M sterile PBS.
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2.2.3 Surgical procedures
Rats were placed in a Harvard anesthesia box (Harvard Apparatus, Holliston, MA) and
anesthetized with 4% isoflurane (Baxter Corporation, Mississauga, ON) mixed with 2.0 L/min
of oxygen. Once fully anesthetized, the head of the rat was shaved to expose the scalp. Rats
were then transferred to a Kopf stereotaxic frame (David Kopf Instruments, Tujunga, CA) to
secure head position. While under anesthesia, rat body temperature was maintained at 37°C by
heating pad. Anesthesia was maintained at 2.5% isoflurane for the duration of surgery.
Prior to incision, the rat’s scalp was sanitized with soap, followed by 70% ethanol and
iodine; to minimize risk of infection. A skin incision was then made along the scalp, exposing
the rat skull and bregma. Pre-determined stereotaxic coordinates

195

(in reference to bregma)

were used to locate the targeted IC brain region (anterior/posterior (AP): -1.00 mm,
medial/lateral (ML): ±6.50 mm, dorsal/ventral (DV): -7.00 mm) (Figure 4). Upon
identification, a single burr hole was drilled into the skull to allow for the 1 µL unilateral
injection of ET-1, IA or PBS into the right (R) or left (L) IC (n=8/experimental group).
Injections were performed at a rate of 0.2 µL/min using a 32-guage Hamilton syringe
(Hamilton Company, Reno, NV), followed by an in situ period of 5 min to prevent solution
backflow. Post-injection, the burr hole was covered with bone wax (Ethicon LLC, Puerto Rico,
TX) prior to suturing of the incision site. Rats were then administered a 1 mL/kg subcutaneous
injection of buprenorphine analgesic (Champion Alstoe Inc., Whitby, ON) and a 0.03 mL
intramuscular injection of Baytril antibiotic (Bayer Inc., Toronto, ON). Following surgery, rats
were returned to their individual cage and monitored closely until sternal recumbency was
regained. Rats were then left freely until behaviour testing and euthanasia 28 d post-surgery.
Experimental groups were balanced during each surgical day to avoid the introduction of dayspecific confounding variables.
In addition to the aforementioned groups, an additional control group of no injection
(NI) animals (n=6) were included in this study. Aside from not receiving a burr hole within the
skull, or intracranial injection, these rats underwent identical surgical procedures, remaining
under anesthesia for an equivalent amount of time as injection groups. A post-surgery mortality
rate of 3.8% was observed in PBS-injected control animals (n=2), with a 0% mortality rate
observed in all other experimental groups.
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IC

Figure 4. Schematic representation of targeted insular cortex brain region. (A) Predetermined stereotaxic coordinates were used to locate the IC (red star), in reference to bregma
(blue dot). Upon identification, a single burr hole was drilled into the rat’s skull to allow for
the 1 µL unilateral injection of ET-1, IA or PBS into (B) the right or left IC (purple region). IC
= insular cortex
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2.3 Behaviour Testing
2.3.1 Prepulse inhibition of the acoustic startle response
Twenty-eight days post-surgery, rats were subjected to behaviour testing. PPI of the
ASR was used to assess deficits in sensorimotor gating following IC injury

139,160,161,184

.

Experimental groups were balanced throughout behavioural testing to avoid the introduction
of day-specific confounding variables.
Two days prior to PPI measurement (day 26), rats were randomly assigned to 1 of 4
startle boxes (Med Associates Inc., St. Albans, VT) and subjected to four acclimation periods
(2/day) (Figure 5). Rats were placed into the same startle chamber for the duration of their
behavioural testing to avoid the introduction of instrument-specific confounding variables.
All rats were held inside the startle chambers using plastic holders. These holders were
then attached to transducer platforms, which were used to measure motor output; a reliable
indicator of the ASR 184. During the first three acclimation periods, rats were exposed to 65 dB
of white background noise for 5 min. For the final acclimation period, rats were subjected to
65 dB of white background noise for 5 min, followed by 12 acoustic startle stimuli increasing
in volume by 5 dB intervals (65-120 dB). This measured and accounted for differences in
individual startle responses between rats, as some naturally startled more or less than others.
Sensitivity of the transducer platform was then adjusted, based off natural ASR to these 12
stimuli.
Following acclimation, rats underwent PPI testing (day 28) comprised of three phases:
an acclimation phase, habituation phase (Block I) and PPI phase (Block II). During the
acclimation phase, rats were exposed to 65 dB of white background noise for 5 min. This was
immediately followed by Block I, in which rats were subjected to 50 identical trials containing
an acoustic startle stimulus of 120 dB, administered every 20 s for a duration of 20 ms.
Throughout Block II, rats were exposed to 50 randomized trials of varying prepulse stimuli,
occurring every 20 s (Table 1).
Startle response data was collected and analyzed using Startle Reflex 5.95 software
(Med Associates Inc., St. Albans, VT). PPI was calculated for each rat as a comparison to their
individual startle response, using the following formula:
% PPI = [1 – (PPI-pulse trial amplitude / pulse alone trial amplitude)]*100
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Figure 5. Experimental timeline. Six-month old male Wistar rats underwent stereotaxic
surgery to receive a 1 µL unilateral intracranial injection of ET-1 (20 pmol/µL), IA (5 µg/µL)
or PBS (0.1 M) into the right or left IC. An additional control group of NI rats received identical
surgical procedures, without reagent injection. At 26 and 27 d post-surgery, rats were subjected
to four acclimation periods (2/day), in preparation for the PPI behaviour test. At 28 d postsurgery, rats underwent PPI behaviour testing prior to euthanasia.
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Table 1. Prepulse and startle stimuli parameters used during Block II of the PPI
behaviour test. Rats were exposed to 50 randomized trials of varying prepulse intensity and
interstimulus intervals (ISIs) to examine changes in sensorimotor gating following IC injury.
Number
of Trials

Prepulse
Intensity

Prepulse
Duration

Startle
Intensity

Startle
Duration

Interstimulus
Interval

Trial A

10

-

-

120 dB

20 ms

-

Trial B

10

75 dB

4 ms

120 dB

20 ms

30 ms

Trial C

10

75 dB

4 ms

120 dB

20 ms

100 ms

Trial D

10

85 dB

4 ms

120 dB

20 ms

30 ms

Trial E

10

85 dB

4 ms

120 dB

20 ms

100 ms
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2.4 Euthanasia
Immediately following behaviour testing (day 28), rats were euthanized via 2.5 mL
intraperitoneal injection of pentobarbital (48 mg/mL; Bimeda-MTC, Cambridge, ON). Rats
were transcardially perfused with 200 mL of 0.01 M PBS (pH 7.35), followed by 300 mL of
4% paraformaldehyde (PFA). After perfusion, brain and heart tissue were extracted and
temporarily stored in 4% PFA at 4°C for an additional 24 and 48 h, respectively. Tissue was
then transferred to 30% sucrose and stored at 4°C until sectioned.
2.5 Brain Histology and Immunohistochemistry
2.5.1 Tissue sectioning
Brain tissue was flash frozen in Tissue-Tek® O.C.T. Compound (Sakura Finetek USA
Inc., Torrance, CA) and sectioned into 35 µm coronal sections using the CryoStar NX50
cryostat (Thermo Fisher Scientific, Waltham, MA). Free-floating sections were divided into 6
series (210 µm serial sections) and stored in cryoprotectant solution at -20°C until stained.
2.5.2 Thionine histochemistry
Brain tissue was histologically stained with thionine to visualize cellular Nissl
substance and identify local cell death following IC injury 196. Prior to staining, tissue sections
were washed in 0.01 M PBS (pH 7.35) for 1 h at room temperature to remove residual
cryoprotectant. Sections were then pre-mounted on VWR VistaVision™ microscope slides
(VWR International, Radnor, PA) with 0.3% gelatin (Sigma-Aldrich, Oakville, ON) and left
to air-dry overnight. The next day, mounted sections were rehydrated by immersion into
descending concentrations of ethanol (100%, 95%, 70%, 50%), followed by immersion into
distilled water (dH2O). Sections were then submerged into 0.5% thionin solution for 35 s, prior
to dehydration. During dehydration, sections were exposed to a series of ascending ethanol
concentrations (50%, 70%, 95%, 100%) before cleared in xylene (Caledon Laboratories Ltd.,
Georgetown, ON). Slides were then coverslipped using DePex mounting medium (VWR
International, Radnor, PA) and stored at room temperature.
2.5.3 Immunohistochemistry
Brain tissue was immunohistochemically stained for either (i) activated M1 subtype
microglia, (ii) astrocytes or (iii) neurons, to assess neuroinflammation (microglia/astrocyte
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activation) 197–200 and secondary neuronal damage (loss of neurons)

201,202

post-insular injury.

Activated microglia were identified through detection of the major histocompatibility complex
II (MHC II) molecule, using an OX-6 primary antibody (Lot 554926; BD Biosciences,
Mississauga, ON). Reactive astrocytes were identified through detection of the glial fibrillary
acidic protein (GFAP), using a GFAP primary antibody (Lot G3893; Sigma-Aldrich, Oakville,
ON). Neurons were identified through detection of the DNA-binding neuronal nuclei (NeuN)
protein, using a NeuN primary antibody (Lot MAB377; Sigma-Aldrich, Oakville, ON).
For all three stains, tissue sections were washed in 0.01 M PBS (pH 7.35) for 1 h at
room temperature to remove residual cryoprotectant. Free-floating sections were then
incubated in 1% hydrogen peroxide (H2O2) for 10 min prior to blocking in 2% horse serum
(Lot H0146, Sigma-Aldrich, Oakville, ON) for 1 h at room temperature. Sections were then
incubated in diluted primary antibody solution (OX-6, GFAP or NeuN) overnight at 4°C (Table
2). The next day, sections were briefly washed with 0.01 M PBS (pH 7.35) for 15 min prior to
incubation in diluted (1:500) biotinylated anti-mouse IgG secondary antibody solution (Lot
31806; Thermo Fisher Scientific, Waltham, MA). Tissue remained in secondary antibody
solution for 1 h at room temperature. Sections were then incubated in 2% Avidin-Biotin
Complex (ABC) reagent (Lot PI32020; Thermo Fisher Scientific, Waltham, MA) for 1 h.
Sections were then stained with 0.05% 3,3’-diaminobenzidine tetrahydrochloride (DAB;
Sigma-Aldrich, Oakville, ON) diluted in 1% H2O2 for 5 min (OX-6) or 30 s (GFAP; NeuN).
Sections were mounted onto VWR VistaVision™ microscope slides with 0.3% gelatin and left
to air-dry overnight. The following day, sections were dehydrated via exposure to ascending
ethanol concentrations (50%, 70%, 95%, 100%) and cleared in xylene. Slides were then
coverslipped using DePex mounting medium and stored at room temperature. Each staining
cohort included tissue representation from all experimental groups to eliminate day-specific
confounding factors associated with natural variance in staining procedures.
2.6 Heart Histology
Heart tissue preparation and analysis was completed with assistance from Dr. Brittany
Balint (Vulnerable Brain Lab, Schulich School of Medicine & Dentistry, Western University)
and Caroline O’Neil (Molecular Pathology Facility, Robarts Research Institute, Western
University).
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Table 2. Product summary of primary antibodies used for the immunohistochemical
staining of brain tissue.
Antibody

Host Species

Dilution Ratio

Cellular Target

OX-6

Mouse - monoclonal

1:1000

Activated microglia

GFAP

Mouse - monoclonal

1:2000

Reactive astrocytes

NeuN

Mouse - monoclonal

1:1000

Neurons
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2.6.1 Tissue sectioning
Excess connective tissue was removed from rat hearts, prior to placement into tissue
cassettes (Thermo Fisher Scientific, Waltham, MA) and dehydration via immersion into
ascending ethanol concentrations (70%, 95%, 100%). Heart tissue was then cleared in xylene,
before embedded in 65°C paraffin wax. Hearts were embedded to cassette blocks in their
anterior anatomical position.
Prior to sectioning, heart tissue was rehydrated in an ice bath for 15 min. Tissue was
then sliced into 5 µm coronal sections using the Leica CM350 microtome (Leica Biosystemcs
Inc., Concord, ON). Ribbons of 5-6 tissue sections were then placed into a warm water bath to
allow for flattening and separation of tissue. Individual sections were then mounted to
SuperFrost Plus microscope slides (VWR International, Radnor, PA) and incubated overnight
at 42°C for optimal adhesion. Slides were stored at -20°C until stained.
2.6.2 Masson’s trichrome histochemistry
Heart tissue was histologically stained with Masson’s trichrome to identify regions of
collagen deposition post-insular injury, indicating cardiac fibrosis 203,204. Prior to staining, premounted tissue sections were deparaffinized in xylene for 15 min. Sections were then
rehydrated by immersion into descending concentrations of ethanol (100%, 95%, 70%),
followed by immersion into dH2O. Tissue sections were then placed into Bouin’s fixative at
56°C for 1 h, prior to treatment with Weigert’s hematoxylin for 10 min. Sections were then
stained with Biebrich scarlet-acid fuchsin solution for 2 min and rinsed using 1%
phosphotungstic acid. Tissue was then transferred to an Aniline blue dye for 5 min and rinsed
using 1% acetic acid, prior to dehydration. During dehydration, sections were rapidly exposed
to a series of ascending ethanol concentrations (95%, 100%) before cleared in xylene. Slides
were then coverslipped using DePex mounting medium. Heart tissue was stained red, blue and
purple; representing cardiomyocytes, collagen fibers and nuclei, respectively.
2.7 Tissue Analysis
2.7.1 Imaging and quantification
All stained tissue sections were visualized and imaged using a Nikon Eclipse Ni-E
upright microscope with Nikon DS Fi2 colour camera and NIS Elements imaging software
(Version 4.30.02; Nikon Instruments Inc., Melville, NY). The experimenter remained blinded
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to all group identities throughout quantification to eliminate bias observations. Brain tissue
stained with thionine confirmed injury location within the IC and was used to select a staining
cohort (n=6) for each experimental group, dependent on precision of injury location. One NI
animal was excluded as an outlier during quantification, due to abnormal amounts of
neuroinflammation (activated microglia).
To analyze OX-6 and GFAP-stained brain tissue, four stitched photomicrographs (per
animal; 10X magnification) of 35 µm coronal sections were imaged for each stain (AP: +2.70
mm, +1.20 mm, -0.40 mm and -3.30 mm, in reference to bregma). Using ImageJ software
(Version 1.45; National Institute of Health, Bethesda, MD), % area coverage densitometry
measurements of OX-6 and GFAP immunoreactivity were quantified for four regions of
interest (ROI): forceps minor, corpus callosum, internal capsule and ventroposterior (VP)
thalamus (Figure 6). For forceps minor (AP: +2.70 mm), internal capsule (AP: -3.30 mm) and
VP thalamus assessment (AP: -3.30 mm), analysis was performed using a single coronal
section. Furthermore, OX-6 and GFAP immunoreactivity was quantified in both hemispheres;
comparing regions contralateral and ipsilateral to the injection site. To quantify OX-6 and
GFAP immunoreactivity within the corpus callosum, % area coverage measurements were
calculated and averaged for three coronal sections (AP: +1.20 mm, -0.40 mm and -3.30 mm,
in reference to bregma).
To analyze NeuN-stained brain tissue, four stitched photomicrographs (per animal;
10X magnification) of 35 µm coronal sections were imaged (AP: +2.70 mm, +1.60 mm, -2.12
mm and -3.30 mm, in reference to bregma). Using NIS Elements imaging software, automated
cell count measurements of NeuN immunoreactivity were performed for five ROIs: PFC (AP:
+2.70 mm), ACC (AP: +1.60 mm), amygdala (AP: -2.12 mm), hypothalamus (AP: -2.12 mm)
and VP thalamus (AP: -3.30 mm) (Figure 7). For all five ROIs, NeuN immunoreactivity was
quantified in both hemispheres of a single coronal section, comparing regions contralateral and
ipsilateral to the injection site.
To analyze Masson’s Trichrome-stained heart tissue, eight stitched photomicrographs
(per animal; 10X magnification) of 5 µm coronal sections were imaged from the left atrium
(LA). Using ImageJ software, colour deconvolution was performed to isolate blue-stained
tissue (collagen fibers). Percent area coverage of LA cardiac fibrosis was identified as the
averaged total fraction of blue-stained tissue present within the eight imaged tissue regions.
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Figure 6. Schematic representation of brain ROIs selected for OX-6 and GFAP analysis.
To investigate the presence of neuroinflammation, densitometry measurements of OX-6 or
GFAP immunoreactivity were performed within the (A) forceps minor, (B1-B3) corpus
callosum, (C) internal capsule and (D) ventroposterior thalamus. Purple regions represent areas
of interest. AP = anterior/posterior stereotaxic coordinate (in reference to bregma).
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Figure 7. Schematic representation of brain ROIs selected for NeuN analysis. To
investigate the presence of neuronal loss, automated cell count measurements of NeuN
immunoreactivity were performed within the (A) prefrontal cortex, (B) anterior cingulate
cortex, (C) amygdala, (D) hypothalamus and (E) ventroposterior thalamus. Purple regions
represent areas of interest. AP = anterior/posterior stereotaxic coordinate (in reference to
bregma).
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2.7.2 Statistical analysis
Statistical analyses were conducted using GraphPad Prism software (Version 7.0;
GraphPad Software Inc., La Jolla, CA). Statistical significance of dependent variables was
assessed through two-way analysis of variance (ANOVA) followed by Tukey’s multiple
comparison test. Data are presented as mean ± standard error of the mean (SEM), with a
statistical alpha of 0.05.
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Section 3: RESULTS
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3.1 Qualitative Confirmation of Targeted Insular Damage
Initial qualitative analysis of injury location was performed to confirm IC damage.
Brain tissue was histologically stained with thionine to identify Nissl bodies (Figure 8A,B),
indicating the presence of healthy cell populations. Due to the rapid recovery rate of ischemic
injury (induced by ET-1), infarct scars were often difficult to clearly visualize at low
magnification (2X objective lens). However, use of a 20X objective lens revealed a loss of
neurons and increased presence of supporting glial cells within the IC of injured groups
(IA/ET-1), compared to uninjured groups (PBS/NI; Figure 8A,B). Additionally, brain tissue
was immunohistochemically stained with NeuN (Figure 8C,D) and OX-6 (Figure 8E,F) for
secondary confirmation of targeted IC damage. Staining of tissue with NeuN was used to
identify neurons and confirmed neuronal loss within the IC of injured groups (IA/ET-1; Figure
8C). Tissue stained with OX-6 identified substantial amounts of activated microglia present
within the IC of injured groups (IA/ET-1; Figure 1E), further confirming local damage.
3.2 Behavioural Assessment
3.2.1 Left insular damage corresponds with an observed trend of reduced prepulse inhibition
In developing this rodent model of focal insular ischemic stroke, it was crucial to
establish an accompanying behaviour test, capable of identifying autonomic deficits postinsular injury. More importantly, successful implementation of this test could provide valuable
insight into the lateralization of IC autonomic function. To identify and evaluate autonomic
dysfunction, PPI of the ASR was measured 28 d following insular injury; indicating functional
changes in sensorimotor gating. In the past, blockage of the sympathetically-controlled
noradrenergic system has corresponded with impaired sensorimotor gating

177

. As such, rats

subjected to IC injury, causing decreased sympathetic outflow, were expected to display a
reduction in PPI; with damage to the IC disrupting sympathetic control of the noradrenergic
system, inhibiting normal sensorimotor gating processes.
Administration of the ASR subjected rats to 40 randomized trials of varying prepulse
stimuli, changing in stimulus intensity (75 dB or 85 dB) and ISI (30 ms or 100 ms). An
additional 10 trials presented startle stimuli only, to attain baseline startle responses of each
rat. Percent PPI was calculated as the startle reduction of this averaged baseline measurement,
with a higher % PPI representing a greater reduction in startle response.
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Figure 8. Qualitative confirmation of insular damage. Representative 2X photomicrographs
of coronal rat brain tissue histologically stained with (A,B) thionine, or
immunohistochemically stained with (C,D) NeuN or (E,F) OX-6, 28 d following intracranial
injection of PBS (n=7), IA (n=8), ET-1 (n=8) or NI (n=6) into the right or left insular cortex.
Outlined areas represent higher-magnified regions (20X) of the insular cortex. At 28 d postinjection, injured rats displayed neuronal loss (A,C: IA/ET-1) and enhanced microgliosis (A,E:
IA/ET-1) compared to uninjured groups (A,C,E: PBS; B,D,F: NI), confirming insular damage.
Scale bar = 500 µm (2X) or 50 µm (20X). IC = insular cortex, PBS = phosphate-buffered
saline, IA = ibotenic acid, ET-1 = endothelin-1, NI = no injection
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At 28 d post-insular injury, rats subjected to left IC damage (IA/ET-1) displayed an
observed trend of deficient sensorimotor gating. Administration of a 75 dB prepulse, with 30
ms ISI, caused a notable decrease in % PPI of IA-L (60.69% ± 14.05%) and ET1-L (59.58% ±
10.89%) groups, compared to (i) IA-R (96.24% ± 12.93%) and ET1-R (88.51% ± 13.78%)
injury groups and (ii) PBS-L (102.31% ± 12.65%) and NI (100.00% ± 6.00%) control groups
(Figure 9A). However, completion of a two-way ANOVA identified no significant effect of
injury (F(3,50) = 2.42, p = 0.08) and/or insular damage lateralization (F(1,50) = 2.38, p = 0.13).
Additional trials consisting of (i) 75 dB prepulse with 100 ms ISI (Figure 9B), (ii) 85 dB
prepulse with 30 ms ISI (Figure 9C) and (iii) 85 dB prepulse with 100 ms ISI (Figure 9D)
displayed similar results, demonstrating a minor decrease in % PPI of left injury groups
(IA/ET-1). However, these observed reductions were not as substantial as the trending deficits
observed after administration of a 75 dB prepulse with 30 ms ISI (Figure 9A).
3.3 Analysis of Brain Immunohistochemistry
3.3.1 Insular damage enhances white matter microgliosis, but not astrogliosis, in the corpus
callosum
Neuroinflammation is a known consequence of ischemic stroke, vital for post-ischemic
tissue repair

35–37,53

. However, not all neuroinflammation has been associated with beneficial

effects. In particular, post-stroke chronic inflammation, of remote grey and white matter
regions, has been shown to perpetuate secondary neurodegeneration in brain regions
anatomically connected to the primary ischemic infarct
and recovery time

87–91

; worsening prognostic outcomes

68,72,73

. We therefore used our established rodent model of focal insular

ischemic stroke to identify remote regions of secondary cerebral inflammation that may
contribute to the functional autonomic deficits observed, both clinically and experimentally,
post-insular injury.
Initial analysis of white matter neuroinflammation was performed in the corpus
callosum; the largest commissural fibre of the brain. Brain tissue was immunohistochemically
stained with OX-6 or GFAP to identify activated microglia or reactive astrocytes, respectively,
as both microgliosis and astrogliosis are known mechanisms of neuroinflammation

35–37,53,61

.

Densitometry measurements of % area coverage were quantified as the averaged total fraction
of OX-6 or GFAP immunolabelled cells present within the corpus callosum of three coronal
tissue sections.
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Figure 9. Left insular damage corresponds with an observed trend of reduced prepulse
inhibition. Percent PPI of the ASR was measured 28 d following intracranial injection of PBS
(n=7), IA (n=8), ET-1 (n=8) or NI (n=6) into the right or left insular cortex. Rats were subjected
to randomized trials of varying prepulse stimuli administered at (A) 75 dB, 30 ms before startle
stimulus, (B) 75 dB, 100 ms before startle stimulus, (C) 85 dB, 30 ms before startle stimulus
or (D) 85 dB, 100 ms before startle stimulus. Damage to the left insular cortex notably reduced
% PPI, particularly during administration of a (A) 75 dB prepulse, 30 ms prior to startle
stimulus. Data is presented as mean ± SEM and normalized to the NI group. IC = insular cortex,
PPI = prepulse inhibition, PP = prepulse, ISI = interstimulus interval, NI = no injection, PBS
= phosphate-buffered saline, IA = ibotenic acid, ET-1 = endothelin-1
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At 28 d post-insular injury, OX-6 staining for activated microglia presented a
significant effect of injury (F(3,38) = 12.59, p < 0.01, two-way ANOVA). Left IC damage
resulted in enhanced corpus callosum microgliosis in rats injected with IA (9.82% ± 2.06%) or
ET-1 (8.15% ± 2.24%), compared to PBS (3.32% ± 0.54%) and NI (1.41% ± 0.31%) rats
(Figure 10A-C). Increased corpus callosum microgliosis was also observed following injection
of IA (9.60% ± 1.71%) or ET-1 (5.71% ± 1.78%) into the right IC (Figure 10A,C), indicating
no significant effect of insular damage lateralization (F(1,38) = 0.56, p = 0.46, two-way
ANOVA). Rats subjected to injection of PBS into the right IC also displayed minimal
microgliosis (2.84% ± 0.47%), similar to the PBS-L group (Figure 10A,C). Upon completion
of Tukey’s multiple comparison test, a significant difference in corpus callosum microgliosis
between NI/IA-L (p = 0.01), NI/IA-R (p = 0.01) and PBS-R/IA-R (p = 0.04) groups was
confirmed (Figure 10C). A significant difference between injured groups (IA/ET-1; p = 0.26)
or uninjured groups (NI/PBS; p = 0.83) was not observed (Figure 10C). GFAP staining for
reactive astrocytes indicated no significant differences in corpus callosum astrogliosis between
experimental groups (F(3,38) = 1.53, p = 0.22, two-way ANOVA), with all groups displaying
similar measurements of GFAP % area coverage: NI (29.89% ± 2.67%), PBS-L (27.27% ±
4.38%), PBS-R (24.38% ± 2.59%), IA-L (26.66% ± 1.96%), IA-R (22.57% ± 3.62%), ET1-L
(23.31% ± 3.50%) and ET1-R (23.61% ± 2.16%) (Figure 11A-C).
3.3.2 Insular damage does not enhance white matter microgliosis or astrogliosis in the forceps
minor
In addition to the corpus callosum, neuroinflammation was analyzed within the forceps
minor. While the corpus callosum is anatomically proximal to the injured insular site, the
forceps minor is a distal fibre bundle located anteriorly within the frontal lobe; allowing for
the assessment of neuroinflammatory spread. Densitometry measurements of % area coverage
were quantified as the total fraction of OX-6 (microglia) or GFAP (astrocytes) immunolabelled
cells present within the forceps minor of one coronal tissue section. Comparisons of
microgliosis or astrogliosis within the contralateral and ipsilateral forceps minor were
performed to account for unilateral IC damage.
At 28 d post-insular injury, OX-6 staining for activated microglia presented no
significant effect of injury for both left (F(3,38) = 2.65, p = 0.06, two-way ANOVA) and right
(F(3,38) = 1.65, p = 0.19, two-way ANOVA) experimental groups. Following damage to the left
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Figure 10. Insular damage significantly increases white matter microgliosis within the
corpus callosum. Representative 2X photomicrographs of OX-6 immunohistochemical
stained coronal rat brain tissue, 28 d following intracranial injection of (A) PBS, IA, ET-1
(n=6/experimental group) or (B) no injection (n=5) into the right or left insular cortex. Outlined
areas represent higher-magnified regions (20X) of the corpus callosum. (C) Quantitative
analysis revealed significant increases in microglia activation (% area coverage) within the
corpus callosum 28 d following insular injury. Data is presented as mean ± SEM. Nonmatching letters indicate significant differences between experimental groups (p < 0.05, twoway ANOVA followed by Tukey’s multiple comparison test). Scale bar = 500 µm (2X) or 50
µm (20X). IC = insular cortex, PBS = phosphate-buffered saline, IA = ibotenic acid, ET-1 =
endothelin-1, NI = no injection
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Figure 11. Insular damage does not enhance white matter astrogliosis within the corpus
callosum. Representative 2X photomicrographs of GFAP immunohistochemical stained
coronal rat brain tissue, 28 d following intracranial injection of (A) PBS, IA, ET-1
(n=6/experimental group) or (B) no injection (n=5) into the right or left insular cortex. Outlined
areas represent higher-magnified regions (20X) of the corpus callosum. (C) Quantitative
analysis revealed no significant differences in corpus callosum astrogliosis (% area coverage)
between experimental groups. Data is presented as mean ± SEM. Scale bar = 500 µm (2X) or
50 µm (20X). IC = insular cortex, PBS = phosphate-buffered saline, IA = ibotenic acid, ET-1
= endothelin-1, NI = no injection
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or right IC, minimal levels of microgliosis within the ipsilateral forceps minor of IA (IA-L
3.91% ± 1.33%; IA-R 3.62% ± 1.51%) and ET-1 (ET1-L 2.55% ± 0.79%; ET1-R 2.50% ±
0.85%) groups were observed, compared to PBS (PBS-L 2.55% ± 0.52%; PBS-R 1.99% ±
0.50%) and NI (1.19% ± 0.32%) control animals (Figure 12A-D). Furthermore, significant
differences between microglia activation within the contralateral and ipsilateral forceps minor
of both left (Figure 12C; F(1,38) = 0.01, p = 0.92, two-way ANOVA) and right (Figure 12D;
F(1,38) = 0.14, p = 0.71, two-way ANOVA) experimental groups were not observed.
GFAP staining for reactive astrocytes indicated no significant differences in ipsilateral
forceps minor astrogliosis within left (F(3,38) = 0.89, p = 0.46, two-way ANOVA) and right
(F(3,38) = 1.06, p = 0.38, two-way ANOVA) experimental groups, with all groups displaying
similar measurements of GFAP % area coverage: NI (32.62% ± 7.02%), PBS-L (34.23% ±
4.42%), PBS-R (31.36% ± 4.66%), IA-L (28.44% ± 3.23%), IA-R (28.00% ± 3.43%), ET1-L
(33.53% ± 3.60%) and ET1-R (25.52% ± 4.87%) (Figure 13A-D). Similar levels of reactive
astrocytes were also observed within the contralateral forceps minor, revealing no significant
differences in astrogliosis between the contralateral and ipsilateral forceps minor for both left
(Figure 13C; F(1,38) = 1.06, p = 0.31, two-way ANOVA) and right (Figure 13D; F(1,38) = 0.16,
p = 0.69, two-way ANOVA) experimental groups.
3.3.3 Insular damage enhances white matter microgliosis, but not astrogliosis, in the
ipsilateral internal capsule
Additional neuroinflammatory analysis was performed within the internal capsule, a
subcortical fibre bundle located posteriorly to the injured IC region. Quantification of
neuroinflammation within this white matter region was of particular interest, as the internal
capsule comprises the corticobulbar tract; transferring information between the cortex and
brainstem. With the brainstem home to numerous autonomic cardiovascular centres

2,108,205

,a

neuroinflammatory response within the internal capsule could provide important insight into
secondary neurodegeneration of autonomic brainstem structures post-insular ischemic stroke.
Densitometry measurements of % area coverage were quantified as the total fraction of OX-6
(microglia) or GFAP (astrocytes) immunolabelled cells present within the internal capsule of
one coronal tissue section. Comparisons of microgliosis or astrogliosis within the contralateral
and ipsilateral internal capsule were performed to account for unilateral IC damage.
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Figure 12. Insular damage does not enhance white matter microgliosis within the forceps
minor. Representative 2X photomicrographs of OX-6 immunohistochemical stained coronal
rat brain tissue, 28 d following intracranial injection of (A) PBS, IA, ET-1 (n=6/experimental
group) or (B) no injection (n=5) into the right or left insular cortex. Outlined areas represent
higher-magnified regions (20X) of the ipsilateral forceps minor. (C, D) Quantitative analysis
revealed no significant differences in contralateral and ipsilateral forceps minor microgliosis
(% area coverage) within, and between, experimental groups. Data is presented as mean ±
SEM. Scale bar = 500 µm (2X) or 50 µm (20X). IC = insular cortex, PBS = phosphate-buffered
saline, IA = ibotenic acid, ET-1 = endothelin-1, NI = no injection
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Figure 13. Insular damage does not enhance white matter astrogliosis within the forceps
minor. Representative 2X photomicrographs of GFAP immunohistochemical stained coronal
rat brain tissue, 28 d following intracranial injection of (A) PBS, IA, ET-1 (n=6/experimental
group) or (B) no injection (n=5) into the right or left insular cortex. Outlined areas represent
higher-magnified regions (20X) of the ipsilateral forceps minor. (C, D) Quantitative analysis
revealed no significant differences in contralateral and ipsilateral forceps minor astrogliosis (%
area coverage) within, and between, experimental groups. Data is presented as mean ± SEM.
Scale bar = 500 µm (2X) or 50 µm (20X). IC = insular cortex, PBS = phosphate-buffered
saline, IA = ibotenic acid, ET-1 = endothelin-1, NI = no injection
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At 28 d post-insular injury, OX-6 staining for activated microglia presented a
significant effect of injury for both left (F(3,38) = 9.32, p < 0.01, two-way ANOVA) and right
(F(3,38) = 7.87, p < 0.01, two-way ANOVA) experimental groups. Following damage to the left
or right IC, enhanced levels of microgliosis within the ipsilateral internal capsule of IA (IA-L
7.83% ± 1.61%; IA-R 11.55% ± 2.45%) and ET-1 (ET1-L 6.82% ± 1.06%; ET1-R 5.66% ±
1.61%) groups were observed, compared to PBS (PBS-L 3.61% ± 0.85%; PBS-R 3.75% ±
1.06%) and NI (2.09% ± 0.46%) control animals (Figure 14A-D). Similar levels of
microgliosis occurred in the ipsilateral internal capsule of both left and right experimental
injury groups, indicating no significant effect of insular damage lateralization (F (1,38) = 0.56, p
= 0.46, two-way ANOVA). Upon completion of Tukey’s multiple comparison test, a
significant difference in ipsilateral internal capsule microgliosis between NI/IA-L (p < 0.01),
NI/IA-R (p < 0.01), NI/ET1-L (p = 0.01), PBS-L/IA-L (p = 0.04) and PBS-R/IA-R (p < 0.01)
groups was confirmed (Figure 14C,D). A significant difference between injured groups
(IA/ET-1; p = 0.10) or uninjured groups (NI/PBS; p = 0.74) was not observed (Figure 14C,D).
Furthermore, a significant difference between microglia activation within the ipsilateral and
contralateral internal capsule was observed for both left (F(1,38) = 9.10, p < 0.01, two-way
ANOVA) and right (F(1,38) = 6.03, p = 0.02, two-way ANOVA) experimental groups (Figure
14C,D). While IC damage caused enhanced internal capsule microgliosis both contralaterally
and ipsilaterally, greater levels of microglia activation were observed within the ipsilateral
internal capsule of IA-L (ipsilateral = 7.83% ± 1.61%; contralateral = 4.36% ± 1.06%), IA-R
(ipsilateral = 11.55% ± 2.45%; contralateral = 4.94% ± 1.09%), ET1-L (ipsilateral = 6.82% ±
1.06%; contralateral = 3.92% ± 0.61%) and ET1-R (ipsilateral = 5.66% ± 1.61%; contralateral
= 3.80% ± 1.16%) groups (Figure 14C,D). Upon completion of Tukey’s multiple comparison
test, a significant difference between microgliosis within the contralateral and ipsilateral
internal capsule of the IA-R group (p = 0.02) was confirmed (Figure 14D).
GFAP staining for reactive astrocytes indicated no significant differences in ipsilateral
internal capsule astrogliosis within left (F(3,38) = 1.37, p = 0.27, two-way ANOVA) and right
(F(3,38) = 0.34, p = 0.80, two-way ANOVA) experimental groups, with all groups displaying
similar measurements of GFAP % area coverage: NI (29.76% ± 8.26%), PBS-L (29.50% ±
4.56%), PBS-R (28.59% ± 5.58%), IA-L (24.64% ± 2.15%), IA-R (25.30% ± 2.72%), ET1-L
(33.53% ± 3.60%) and ET1-R (26.17% ± 5.63%) (Figure 15A-D). Similar levels of reactive
astrocytes were also observed within the contralateral internal capsule, revealing no significant
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Figure 14. Insular damage significantly increases white matter microgliosis within the
ipsilateral internal capsule. Representative 2X photomicrographs of OX-6
immunohistochemical stained coronal rat brain tissue, 28 d following intracranial injection of
(A) PBS, IA, ET-1 (n=6/experimental group) or (B) no injection (n=5) into the right or left
insular cortex. Outlined areas represent higher-magnified regions (20X) of the ipsilateral
internal capsule. (C, D) Quantitative analysis revealed significant increases in microglia
activation (% area coverage) within the ipsilateral internal capsule 28 d following insular
injury. Data is presented as mean ± SEM. Non-matching letters indicate significant differences
between experimental groups (p < 0.05, two-way ANOVA followed by Tukey’s multiple
comparison test). Scale bar = 500 µm (2X) or 50 µm (20X). IC = insular cortex, PBS =
phosphate-buffered saline, IA = ibotenic acid, ET-1 = endothelin-1, NI = no injection
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Figure 15. Insular damage does not enhance white matter astrogliosis within the internal
capsule. Representative 2X photomicrographs of GFAP immunohistochemical stained coronal
rat brain tissue, 28 d following intracranial injection of (A) PBS, IA, ET-1 (n=6/experimental
group) or (B) no injection (n=5) into the right or left insular cortex. Outlined areas represent
higher-magnified regions (20X) of the ipsilateral internal capsule. (C, D) Quantitative analysis
revealed no significant differences in contralateral or ipsilateral internal capsule astrogliosis
(% area coverage) within, and between, experimental groups. Data is presented as mean ±
SEM. Scale bar = 500 µm (2X) or 50 µm (20X). IC = insular cortex, PBS = phosphate-buffered
saline, IA = ibotenic acid, ET-1 = endothelin-1, NI = no injection
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differences in astrogliosis between the contralateral and ipsilateral internal capsule for both left
(Figure 8C; F(1,38) = 0.34, p = 0.56, two-way ANOVA) and right (Figure 15D; F(1,38) = 0.06, p
= 0.81, two-way ANOVA) experimental groups.
3.3.4 Insular damage enhances grey matter microgliosis, but not astrogliosis, in the ipsilateral
ventroposterior thalamus
In addition to the aforementioned white matter regions, secondary neuroinflammation
within the grey matter was examined. Specifically, the investigation of inflammation within
the VP thalamus was completed, as this region serves as an important relay centre for the
transmission of cardiac autonomic information between the brainstem and IC

206,207

.

Densitometry measurements of % area coverage were quantified as the total fraction of OX-6
(microglia) or GFAP (astrocytes) immunolabelled cells present within the VP thalamus of one
coronal tissue section. Comparisons of microgliosis or astrogliosis within the contralateral and
ipsilateral VP thalamus were performed to account for unilateral IC damage.
At 28 d post-insular injury, OX-6 staining for activated microglia presented a
significant effect of injury for both left (F(3,38) = 11.17, p < 0.01, two-way ANOVA) and right
(F(3,38) = 19.41, p < 0.01, two-way ANOVA) experimental groups. Following damage to the
left or right IC, enhanced levels of microgliosis within the ipsilateral VP thalamus of IA (IAL 12.55% ± 2.25%; IA-R 11.62% ± 0.70%) and ET-1 (ET1-L 7.30% ± 1.57%; ET1-R 5.40%
± 1.66%) groups were observed, compared to PBS (PBS-L 2.80% ± 0.81%; PBS-R 2.44% ±
0.61%) and NI (1.30% ± 0.44%) control animals (Figure 16A-D). Similar levels of
microgliosis occurred in the ipsilateral VP thalamus of both left and right injury groups,
indicating no significant effect of insular damage lateralization (F(1,38) = 0.81, p = 0.38, twoway ANOVA). Upon completion of Tukey’s multiple comparison test, a significant difference
in ipsilateral VP thalamus microgliosis between NI/IA-L (p < 0.01), NI/IA-R (p < 0.01),
NI/ET1-L (p = 0.01), NI/ET1-R (p = 0.01), PBS-L/IA-L (p < 0.01), PBS-R/IA-R (p < 0.01),
IA-L/ET1-L (p = 0.03) and IA-R/ET1-R (p < 0.01) groups was confirmed (Figure 16C,D). A
significant difference between uninjured control groups (NI/PBS; p = 0.86) was not observed
(Figure 16C,D). Furthermore, a significant difference between microglia activation within the
contralateral and ipsilateral VP thalamus was observed for both left (F (1,38) = 41.47, p < 0.01,
two-way ANOVA) and right (F(1,38) = 52.65, p < 0.01, two-way ANOVA) experimental groups
(Figure 16C,D). Damage to the left or right IC enhanced microgliosis within the ipsilateral VP
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Figure 16. Insular damage significantly increases grey matter microgliosis within the
ipsilateral ventroposterior thalamus. Representative 2X photomicrographs of OX-6
immunohistochemical stained coronal rat brain tissue, 28 d following intracranial injection of
(A) PBS, IA, ET-1 (n=6/experimental group) or (B) no injection (n=5) into the right or left
insular cortex. Outlined areas represent higher-magnified regions (20X) of the ipsilateral
ventroposterior thalamus. (C, D) Quantitative analysis revealed significant increases in
microglia activation (% area coverage) within the ipsilateral ventroposterior thalamus 28 d
following insular injury. Data is presented as mean ± SEM. Non-matching letters indicate
significant differences between experimental groups (p < 0.05, two-way ANOVA followed by
Tukey’s multiple comparison test). Scale bar = 500 µm (2X) or 50 µm (20X). IC = insular
cortex, PBS = phosphate-buffered saline, IA = ibotenic acid, ET-1 = endothelin-1, NI = no
injection
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thalamus, with minimal microglia activation occurring in the contralateral VP thalamus: IA-L
(ipsilateral = 12.55% ± 2.25%; contralateral = 1.35% ± 0.35%), IA-R (ipsilateral = 11.62% ±
0.70%; contralateral = 1.50% ± 0.53%), ET1-L (ipsilateral = 7.30% ± 1.57%; contralateral =
0.75% ± 0.17%) and ET1-R (ipsilateral = 5.40% ± 1.66%; contralateral = 1.13% ± 0.26%)
(Figure 16C,D). Upon completion of Tukey’s multiple comparison test, a significant difference
between microgliosis within the contralateral and ipsilateral VP thalamus of IA-L (p < 0.01),
IA-R (p < 0.01), ET1-L (p < 0.01) and ET1-R (p = 0.01) groups was confirmed (Figure 16C,D).
GFAP staining for reactive astrocytes indicated no significant differences in ipsilateral
VP thalamus astrogliosis within left (F(3,38) = 2.20, p = 0.10, two-way ANOVA) and right
(F(3,38) = 0.72, p = 0.55, two-way ANOVA) experimental groups, with all groups displaying
similar measurements of GFAP % area coverage: NI (10.42% ± 2.02%), PBS-L (14.79% ±
2.93%), PBS-R (13.67% ± 3.22%), IA-L (22.42% ± 3.17%), IA-R (14.39% ± 2.48%), ET1-L
(18.38% ± 3.13%) and ET1-R (16.83% ± 2.12%) (Figure 17A-D). Overall, left and right IC
damage enhanced astrogliosis within the ipsilateral VP thalamus, when compared to the
contralateral region (Figure 17C,D). However, significant differences between contralateral
and ipsilateral astrogliosis were only detected among left experimental injury groups (Figure
17C; F(1,38) = 12.34, p < 0.01, two-way ANOVA). Upon completion of Tukey’s multiple
comparison test, no significant differences were confirmed (Figure 17C).
3.3.5 Insular damage does not generate secondary neuronal loss in remote forebrain regions
As mentioned previously, chronic inflammation within remote grey and white matter
regions, post-ischemic injury, has contributed to secondary neurodegeneration in brain regions
anatomically-connected to the primary ischemic infarct

87–91

. We therefore sought to

investigate the occurrence of neuronal death within the VP thalamus; an identified region in
our insular ischemic model displaying significant amounts of activated microglia.
Quantification of neuronal death was also completed for four additional brain regions of IC
autonomic circuitry: the PFC, ACC, amygdala and hypothalamus. At 28 d post-insular injury,
secondary neuroinflammation was not observed in these regions. However, neuroinflammatory
timing and mechanisms can vary depending on the involved structures and their degree of
axonal connectivity to the primary damaged region

91

. It is therefore possible that secondary

neuroinflammation, and corresponding neurodegeneration, occurred prior to the sacrificed
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Figure 17. Insular damage does not enhance grey matter astrogliosis within the
ventroposterior thalamus. Representative 2X photomicrographs of GFAP
immunohistochemical stained coronal rat brain tissue, 28 d following intracranial injection of
(A) PBS, IA, ET-1 (n=6/experimental group) or (B) no injection (n=5) into the right or left
insular cortex. Outlined areas represent higher-magnified regions (20X) of the ipsilateral
ventroposterior thalamus. (C, D) Quantitative analysis revealed no significant differences in
contralateral and ipsilateral ventroposterior thalamus astrogliosis (% area coverage) within,
and between, experimental groups. Data is presented as mean ± SEM. Scale bar = 500 µm (2X)
or 50 µm (20X). IC = insular cortex, PBS = phosphate-buffered saline, IA = ibotenic acid, ET1 = endothelin-1, NI = no injection
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timepoint of 28 days. Furthermore, with the observed presence of WMI in our model, IC
connectivity to these regions may be impaired, providing additional justification for the
analysis of secondary neurodegeneration.
To investigate the occurrence of neurodegeneration 28 d following IC injury, brain
tissue was immunohistochemically stained with NeuN to identify neurons and quantify
neuronal loss. Automated cell counts of NeuN immunoreactivity were performed to obtain a
single measurement of NeuN+ cells for each ROI. Comparisons of neurodegeneration within
the contralateral and ipsilateral area of each ROI were conducted to account for unilateral IC
damage.
At 28 d post-insular injury, evidence of secondary neuronal loss in remote grey matter
forebrain regions was not observed. Completion of a two-way ANOVA indicated no
significant effect of left IC injury within the ipsilateral region of all ROIs: PFC (Figure 18AC; F(3,38) = 2.49, p = 0.08), ACC (Figure 19A-C; F(3,38) = 0.65, p = 0.59), amygdala (Figure
20A-C; F(3,38) = 0.19, p = 0.90), hypothalamus (Figure 21A-C; F(3,38) = 0.18, p = 0.91) and VP
thalamus (Figure 22A-C; F(3,38) = 0.37, p = 0.78). Similar results were obtained upon
completion of a two-way ANOVA for right experimental groups, with no significant
differences in total neuron amounts observed within the ipsilateral PFC (Figure 18A,B,D;
F(3,38) = 0.67, p = 0.58), ACC (Figure 19A,B,D; F(3,38) = 1.13, p = 0.35), amygdala (Figure
20A,B,D; F(3,38) = 0.38, p = 0.77), hypothalamus (Figure 21A,B,D; F(3,38) = 1.51, p = 0.23) and
VP thalamus (Figure 22A,B,D; F(3,38) = 2.57, p = 0.78). Additionally, similar measurements of
neuronal cell counts were observed between the contralateral and ipsilateral PFC (Figure
18C,D), ACC (Figure 19C,D), amygdala (Figure 20C,D), hypothalamus (Figure 21C,D) and
VP thalamus (Figure 22C,D) of all experimental groups; insinuating an absence of remote
neurodegeneration.
3.4 Analysis of Heart Histology
3.4.1. Left atrial fibrosis of the heart is observed 28 days following insular injury
While early rodent models of MCAO have mimicked the clinical appearance of cardiac
lesions post-ischemic stroke

55,135

, specificity of IC damage in relation to SIHI has yet to be

confirmed. We therefore used our novel rodent model of focal insular ischemic stroke to
examine, for the first time, the downstream effect of selective IC damage on myocardial health
and structural integrity.
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Figure 18. Insular damage does not generate secondary neuronal loss within the
prefrontal cortex. Representative 2X photomicrographs of NeuN immunohistochemical
stained coronal rat brain tissue, 28 d following intracranial injection of (A) PBS, IA, ET-1
(n=6/experimental group) or (B) no injection (n=5) into the right or left insular cortex. Outlined
areas represent higher-magnified regions (20X) of the ipsilateral prefrontal cortex. (C, D)
Quantitative analysis revealed no significant differences in prefrontal cortex contralateral and
ipsilateral neuronal cell numbers within, and between, experimental groups. Cell counts
represent the number of NeuN+ cells within a 1.50 mm2 region of the prefrontal cortex. Data
is presented as mean ± SEM. Scale bar = 500 µm (2X) or 50 µm (20X). IC = insular cortex,
PBS = phosphate-buffered saline, IA = ibotenic acid, ET-1 = endothelin-1, NI = no injection
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Figure 19. Insular damage does not generate secondary neuronal loss within the anterior
cingulate cortex. Representative 2X photomicrographs of NeuN immunohistochemical
stained coronal rat brain tissue, 28 d following intracranial injection of (A) PBS, IA, ET-1
(n=6/experimental group) or (B) no injection (n=5) into the right or left insular cortex. Outlined
areas represent higher-magnified regions (20X) of the ipsilateral anterior cingulate cortex. (C,
D) Quantitative analysis revealed no significant differences in anterior cingulate cortex
contralateral and ipsilateral neuronal cell numbers within, and between, experimental groups.
Cell counts represent the number of NeuN+ cells within a 1.04 mm 2 region of the anterior
cingulate cortex. Data is presented as mean ± SEM. Scale bar = 500 µm (2X) or 50 µm (20X).
IC = insular cortex, PBS = phosphate-buffered saline, IA = ibotenic acid, ET-1 = endothelin1, NI = no injection
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Figure 20. Insular damage does not generate secondary neuronal loss within the
amygdala. Representative 2X photomicrographs of NeuN immunohistochemical stained
coronal rat brain tissue, 28 d following intracranial injection of (A) PBS, IA, ET-1
(n=6/experimental group) or (B) no injection (n=5) into the right or left insular cortex. Outlined
areas represent higher-magnified regions (20X) of the ipsilateral amygdala. (C, D) Quantitative
analysis revealed no significant differences in amygdala contralateral and ipsilateral neuronal
cell numbers within, and between, experimental groups. Cell counts represent the number of
NeuN+ cells within a 0.58 mm2 region of the amygdala. Data is presented as mean ± SEM.
Scale bar = 500 µm (2X) or 50 µm (20X). IC = insular cortex, PBS = phosphate-buffered
saline, IA = ibotenic acid, ET-1 = endothelin-1, NI = no injection
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Figure 21. Insular damage does not generate secondary neuronal loss within the
hypothalamus. Representative 2X photomicrographs of NeuN immunohistochemical stained
coronal rat brain tissue, 28 d following intracranial injection of (A) PBS, IA, ET-1
(n=6/experimental group) or (B) no injection (n=5) into the right or left insular cortex. Outlined
areas represent higher-magnified regions (20X) of the ipsilateral hypothalamus. (C, D)
Quantitative analysis revealed no significant differences in hypothalamus contralateral and
ipsilateral neuronal cell numbers within, and between, experimental groups. Cell counts
represent the number of NeuN+ cells within a 0.58 mm 2 region of the hypothalamus. Data is
presented as mean ± SEM. Scale bar = 500 µm (2X) or 50 µm (20X). IC = insular cortex, PBS
= phosphate-buffered saline, IA = ibotenic acid, ET-1 = endothelin-1, NI = no injection
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Figure 22. Insular damage does not generate secondary neuronal loss within the
ventroposterior
thalamus.
Representative
2X
photomicrographs
of
NeuN
immunohistochemical stained coronal rat brain tissue, 28 d following intracranial injection of
(A) PBS, IA, ET-1 (n=6/experimental group) or (B) no injection (n=5) into the right or left
insular cortex. Outlined areas represent higher-magnified regions (20X) of the ipsilateral
ventroposterior thalamus. (C, D) Quantitative analysis revealed no significant differences in
ventroposterior thalamus contralateral and ipsilateral neuronal cell numbers within, and
between, experimental groups. Cell counts represent the number of NeuN+ cells within a 0.58
mm2 region of the ventroposterior thalamus. Data is presented as mean ± SEM. Scale bar =
500 µm (2X) or 50 µm (20X). IC = insular cortex, PBS = phosphate-buffered saline, IA =
ibotenic acid, ET-1 = endothelin-1, NI = no injection
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Specifically, cardiac tissue was histologically stained with Masson’s trichrome to
identify fibrotic regions. Tissue stained blue represented extensive collagen deposition,
indicating the presence of interstitial fibrosis. For this thesis, fibrosis of the LA was analyzed;
due to the known contribution of LA dysfunction in AF 208,209, and the high clinical prevalence
of AF associated with SIHI 102. Percent area coverage of LA cardiac fibrosis was quantified as
the averaged total fraction of blue-stained tissue present within the LA of eight randomlyselected coronal tissue sections.
At 28 d post-insular damage, a significant effect of injury was observed (F (3,38) = 14.53,
p < 0.01, two-way ANOVA). Left IC damage resulted in enhanced LA fibrosis in IA (6.29%
± 1.62%) and ET-1 (4.49% ± 1.25%) injury groups, compared to PBS (0.79% ± 0.15%) and
NI (0.53% ± 0.09%) control animals (Figure 23A-C). Increased LA fibrosis was also observed
following injection of IA (3.04% ± 0.55%) or ET-1 (5.34% ± 0.86%) into the right IC (Figure
23A,C), indicating no significant effect of insular damage lateralization (F (1,38) = 0.85, p = 0.36,
two-way ANOVA). Rats subjected to injection of PBS into the right IC displayed minimal
fibrotic levels (0.87% ± 0.14%), similar to PBS-L control animals (Figure 23A,C). Upon
completion of Tukey’s multiple comparison test, a significant difference in LA fibrosis
between NI/IA-L (p < 0.01), NI/ET1-R (p = 0.01), PBS-L/IA-L (p < 0.01) and PBS-R/ET1-R
(p = 0.01) groups was confirmed (Figure 23C). A significant difference between injured groups
(IA/ET-1; p = 0.99) or uninjured groups (NI/PBS; p = 1.00) was not observed (Figure 23C).
3.5 Correlative Analysis of Microglia Activation and Cardiac Fibrosis
3.5.1 Increased white and grey matter microglia activation positively correlates with left atrial
cardiac fibrosis
Using our novel rodent model of focal insular ischemic stroke, we have identified the
presence of both (1) secondary white and grey matter microgliosis and (2) LA cardiac fibrosis,
28 d following IC injury. Interestingly, recent studies have hypothesized a causative role of
inflammation in the genesis and perpetuation of myocardial fibrotic remodelling
114,187,188,210,211

. We therefore sought to examine the relationship between remote cerebral

inflammation and cardiac fibrosis; correlating levels of activated microglia within the
ipsilateral forceps minor, corpus callosum, ipsilateral internal capsule or ipsilateral VP
thalamus, to LA fibrosis. Only rats subjected to ischemic injury (ET-1) and saline control
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Figure 23. Left atrial fibrosis of the heart significantly increases following injury to the
insular cortex. Representative 10X photomicrographs of Masson’s trichrome stained coronal
heart tissue, 28 d following intracranial injection of (A) PBS, IA, ET-1 (n=6/experimental
group) or (B) no injection (n=5) into the right or left insular cortex. Tissue stained blue
identifies collagen, indicating fibrosis. (C) Quantitative analysis revealed significant increases
in left atrial fibrosis (% area coverage) 28 d following insular injury. Data is presented as mean
± SEM. Non-matching letters indicate significant differences between experimental groups (p
< 0.05, two-way ANOVA followed by Tukey’s multiple comparison test). Scale bar = 250 µm.
IC = insular cortex, PBS = phosphate-buffered saline, IA = ibotenic acid, ET-1 = endothelin1, NI = no injection
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animals (PBS) were included in this correlative analysis.
At 28 d post-insular ischemic stroke, increased levels of activated microglia
significantly correlated with enhanced LA fibrosis in the ipsilateral forceps minor (Figure 24A;
F(1,18) = 6.06, p = 0.02), corpus callosum (Figure 24B; F(1,18) = 22.91, p < 0.01), ipsilateral
internal capsule (Figure 24C; F(1,18) = 29.38, p < 0.01) and ipsilateral VP thalamus (Figure
24D; F(1,18) = 19.40, p < 0.01). While all four regions displayed a strong positive correlation,
the strongest relationship was observed within brain regions proximal to the infarct site (corpus
callosum: r = 0.75; internal capsule: r = 0.79 and VP thalamus: r = 0.72); compared to the
more distal forceps minor (r = 0.50) (Figure 24A-D). Upon observation of this positive
relationship, linear regression analysis was completed to establish regression lines for each
data set (Figure 24A-D); identifying the overall influence of microglia activation (variable x)
on LA fibrosis (variable y). It is important to note that although these results depict a strong
linear relationship between microgliosis and cardiac fibrosis, the observed association remains
correlative – not causative. As such, a causative implication of neuroinflammation in SIHI can
not yet be discerned.

63

Figure 24. Increased white and grey matter microglia activation positively correlates with
left atrial cardiac fibrosis. Correlative depiction of the significant positive association
between number of activated microglia within the (A) ipsilateral forceps minor (p = 0.02), (B)
corpus callosum (p < 0.01), (C) ipsilateral internal capsule (p < 0.01) or (D) ipsilateral
ventroposterior thalamus (p < 0.01), and extent of left atrial cardiac fibrosis 28 d following
intracranial injection of PBS (grey dots; n=10) or ET-1 (purple dots; n=10) into the left or right
insular cortex. Significance analyzed using the simple linear regression model (p < 0.05).
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Section 4: DISCUSSION
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4.1 Summary of Key Findings
Completion of this thesis was performed with the overall intent of establishing a novel
experimental model of focal ischemic stroke in the rat IC, used to further elucidate the
mechanistic relationship between IC ischemia and SIHI. In doing so, we confirmed, for the
first time, the selective role of IC damage in generating SIHI; reaffirming clinical observations.
To date, experimental studies of SIHI have exclusively involved animal models of MCAO
55,135

. Yet, due to the invasiveness and severity of this procedure 186, observations of SIHI have

been limited to acute timepoints 55,135. In the present study, use of ET-1 produced a focal, and
much less severe, ischemic infarct. As such, we were able to first identify the chronic display
of stroke-induced cardiac fibrosis. At 28 d following IC damage, regions of secondary
microgliosis were located within the corpus callosum, ipsilateral internal capsule and
ipsilateral VP thalamus; a known consequence of ischemic stroke. Due to the recent
implication of inflammation in the manifestation of myocardial fibrotic remodelling
114,187,188,210,211

, microgliosis in these remote regions was correlated to cardiac fibrosis;

demonstrating, for the first time, a positive association between these two physiological
variables. Lastly, development of this rodent model allowed for the implementation of a
behaviour test, used to indirectly assess autonomic deficits of IC damage. Specifically, PPI of
the ASR was analyzed, suggesting a lateralizing trend of left IC dominance in sensorimotor
gating. Overall, with the successful development of this insular stroke model, we have begun
to unravel several pathophysiological outcomes of SIHI; vitally improving current mechanistic
knowledge of this complex brain-heart connection.
4.2 Endothelin-1 vs. Ibotenic Acid
ET-1 is a potent vasoconstrictor, used in this study to induce insular ischemic stroke 57–
59,191,192

. Historically, ET-1 has been recognized as a translational stroke method, best

representing human ischemic conditions

191

. However, resulting ischemia caused by this

technique will injure all structures located at the injection site; including intersecting white
matter fibers

190,193

. Mechanistically, this makes it difficult to conclude whether reported

behavioural and pathological outcomes are a direct effect of the targeted damage, or an indirect
effect of non-specific white matter injury. To overcome this confounding dilemma, the
neurotoxin IA was included as an additional positive control, causing selective neuronal death
within the IC 193,194. IA acts as a glutamate agonist, capable of binding to the NMDA glutamate
66

receptor, an important regulator of Ca2+ transport

212

. Upon administration of IA into the IC,

neuronal membrane NMDA receptors become activated, prompting the influx of extracellular
Ca2+ into IC neurons 212,213. Similar to ischemic stroke 44, the intracellular accumulation of Ca2+
will evoke an excitotoxic cascade, causing neuronal cell death 212,213. In this study, equivalent
results were obtained following the injection of IA or ET-1 into the rat IC. We can therefore
conclude that the acquired behavioural and pathological findings of this thesis are a direct result
of ischemic IC injury, and corresponding physiological processes – not the unspecific damage
of a traversing white matter tract.
4.3 Behavioural Assessment: Prepulse Inhibition of the Acoustic Startle Response
In creating this rodent model of focal insular ischemic stroke, PPI of the ASR was
performed as an accompanying behaviour test. Traditionally, PPI has served as a reliable
measure of sensorimotor gating

139,160,161

; an autonomic process responsible for the filtration

of unnecessary or redundant external stimuli

160–162

. To our knowledge, a direct relationship

between the IC and PPI has not yet been reported. However, due to the known autonomic role
of sensorimotor gating in the regulation of sensory input filtration

160–162

, we used PPI of the

ASR to indirectly measure autonomic outcomes of IC injury. Physiologically, the successful
implementation of this behaviour test could provide crucial insight into the lateralization of IC
autonomic function; a current topic bound by contradicting results.
In 1992, Hachinski and colleagues identified an increased prevalence of severe
sympathetic consequences following occlusion of the right MCA in the rat

135

, suggesting a

parasympathetic dominance of right IC function. Corresponding with this right MCA territorial
damage, was the observed elevation of plasma catecholamines (specifically NE); likely caused
by sympathetic activation of the noradrenergic system 135. Interestingly, Saitoh and colleagues
have previously reported a noradrenergic influence on PPI, observing deficits in sensorimotor
gating following blockage of this hormonal system 177. We therefore expected left IC injury to
impair PPI, reducing attenuation of the ASR. Theoretically, if the left IC truly embodies a
sympathetic dominance of autonomic function, resulting damage would disrupt sympathetic
control and inhibit noradrenergic activation; ultimately impeding normal sensorimotor gating.
At 28 d following IC injury, damage to the left IC caused a notable trend of reduced
PPI, compared to right injury groups (IA/ET-1) and control groups (PBS/NI); supporting the
potential lateralization of IC autonomic function. As part of this behaviour test, rats were
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subjected to assorted prepulse trials, varying in intensity (75 dB and 85 dB) and ISI (30 ms and
100 ms). Mediation of PPI primarily occurs through a fast-acting brainstem circuit

163

.

Although, several studies have also identified the advanced processing of prepulse stimuli at
the forebrain level; capable of exerting a delayed, downstream modulatory effect on PPI
139,145,214,215

. For this reason, PPI is traditionally measured using two ISIs: one of short duration

(30 ms) and one of long duration (100 ms), to assess experimental alterations in brainstem or
forebrain circuitry 184. Intriguingly, while prepulse trials of both ISIs demonstrated a trending
decrease in PPI for left injury groups (IA/ET-1), observed deficits were most substantial
following administration of a 75 dB prepulse with 30 ms ISI. As such, our impaired
observations of PPI are likely the result of autonomic brainstem damage and/or dysfunction,
caused by the downstream effects of left IC injury. However, before such conclusions can be
drawn, it is important to recall that PPI of the ASR has traditionally been used to assess deficits
in sensory processing 160–162. Consequently, this observed trend of reduced PPI following left
IC damage could very-well be attributed to the impairment of normal sensory gating processes,
unrelated to autonomic dysfunction – requiring the future implementation of alternative
metrics capable of directly evaluating autonomic changes post-insular ischemic stroke.
4.4 Insular Ischemic Stroke and Secondary Neuroinflammation
4.4.1 White matter inflammation and axonal degeneration
Following ischemic stroke, clinical imaging studies have identified chronic
inflammation in major white matter tracts, persisting several months into the recovery period
68–71

. Recently, manifestation of this WMI has been implicated in post-stroke prognosis,

contributing to worse functional outcomes 68,72,73. Physiologically, white matter is essential for
proper signal transduction between grey matter regions 66,74. For this transmission to efficiently
occur, a persistent supply of energy is required along the full axon 66. Consequently, damage
to one area, which may arise during ischemia, can destroy the electrophysiological properties
of the entire axon; causing axonal degeneration

66,71

. Overtime, propagation of this axonal

damage will inhibit neuronal communication, resulting in adverse functional deficits

66,68,72,73

.

We therefore sought to identify remote areas of secondary neuroinflammation in our insular
ischemic stroke rodent model. Observed damage in distal white and grey matter regions could
provide valuable mechanistic insight into the neural manifestation of autonomic dysfunction,
and resulting SIHI, following IC ischemia.
68

As anticipated, remote areas of neuroinflammation were identified 28 d following IC
damage, appearing in both white and grey matter regions. In particular, enhanced microglia
activation occurred in the corpus callosum, ipsilateral internal capsule and ipsilateral VP
thalamus of injured groups (IA/ET-1). While minimal amounts of microgliosis were also
observed within the forceps minor, a significant difference between experimental groups was
not identified; likely due to the anatomical distance between its anterior location and our (more
posterior) IC injection site. In this thesis, neuroinflammation was selected as a primary
histological correlate, to allow for the broader observation of insular stroke-induced
pathological changes.
Mechanistically, WMI does not serve as a direct correlate of axonal degeneration.
However, past experimental reports have discerned microgliosis as a reputable assay for axonal
health 65,92,216. Recently, Wang and colleagues positively correlated axonal degeneration to M1
microglia activation, in the corpus callosum of mice subjected to traumatic brain injury

65

.

Physiologically, this makes sense; considering the degradation of axons, or any cellular
component, is naturally accompanied by an accumulation of toxic waste, stimulating activation
of a neuroinflammatory response. Thus, the co-occurrence of both axonal degeneration and
WMI, post-ischemic stroke, is pathologically plausible. We can therefore infer that our
observations of corpus callosum and internal capsule microgliosis correspond with the chronic
degeneration of local axons. This associated white matter injury can disrupt signal
transduction, ultimately leading to the neurodegeneration of remote grey matter regions 90,92.
Pathologically, the neurodegenerative presentation of this distal grey matter damage is
anticipated to elicit a chronic, secondary cascade of remote neuroinflammation. In our current
rat model, significant amounts of activated microglia were identified within the ipsilateral VP
thalamus 28 d following IC damage; further supporting our mechanistic speculation of white
matter axonal degeneration. Intriguingly, the VP thalamus serves as a vital relay centre for the
transmission of autonomic cardiovascular information between the brainstem and IC

108

. As

such, the downstream manifestation of neurodegeneration within this brain region, likely
contributes to associated autonomic deficits of SIHI. Additional staining for histological
markers specific to degeneration, such as Fluoro-Jade B 91,217, should be performed to confirm
this mechanistic prediction of secondary degeneration.

69

4.4.2 Additional causes of microglia activation
In addition to the injured groups (IA/ET-1), basal levels of microgliosis were observed
in our NI rats; insinuating an innate presence of microgliosis. Often, microglia are exclusively
viewed as immune cells of the brain. However, these multifunctional cells participate in an
array of physiological processes, regulating homeostasis and maintaining overall brain health
218

. During the absence of an immune response, microglia will continue to scavenge the CNS:

phagocytosing aged cells, faulty synapses and/or local waste products

218

. Consequently, this

internal cleanup of cellular debris requires the basal activation of M1 microglia; likely
contributing to the observed presence of microgliosis within our NI rats.
4.4.3 Pathological absence of lateralization
As discussed earlier, behavioural measurements of PPI displayed recognizable
differences between left and right insular injury groups, suggesting a lateralization of IC
autonomic function. Consequently, a pathological lateralization of neuroinflammation,
corresponding with this behavioural observation, was anticipated. Yet, at 28 d following IC
damage, similar regions (and amounts) of microgliosis were observed in all injured groups;
despite hemispheric location of the insular injury. Intriguingly, Krause and colleagues recently
identified a co-existence of both sympathetic and parasympathetic regions in the left and right
human IC

130

. Although each hemisphere appears to exhibit a functional autonomic

predominance (right IC = parasympathetic, left IC = sympathetic), opposing autonomic
regions, in each IC, have been observed

130

– blurring the perceived rigidness of IC

lateralization. Experimentally, similar observations of this autonomic variation have been
recognized among cardiac chronotropic sites within the rat IC

219

. It is therefore possible that

damage to the right or left IC may impact both sympathetic and parasympathetic regulatory
sites, negating distinct downstream pathological effects; however, due to the autonomic
predominance of each hemisphere, a lateralization of behavioural deficits was still detected.
Furthermore, the results of this thesis only assess secondary neuroinflammation within
remote forebrain regions; limiting current pathological conclusions. The IC is vital to the
autonomic control of cardiovascular function, transmitting this regulatory effect on the heart
through several brainstem regions

108–110

. Neurologically, the anatomical separation of

sympathetic and parasympathetic pathways involved with this autonomic process remains
most apparent within the brainstem. From the IC, efferent sympathetic output predominantly
70

synapses at the RVLM, while parasympathetic outputs synapse at the DMV and/or NA; both
located within the medulla 2. As such, the pathological representation of IC lateralization may
be more discernable within the brainstem medulla. Interestingly, in our current rodent model,
injured rats (IA/ET-1) exhibited significant amounts of microgliosis within the ipsilateral
internal capsule; a fibre bundle responsible for signal transduction between the cortex and
brainstem. Consequently, chronic display of this internal capsule microgliosis likely
corresponds with a downstream manifestation of brainstem damage, supporting the crucial
need for additional investigation of resulting brainstem pathology.
4.4.4 Insular ischemic stroke and astrogliosis
At 28 d post-insular injury, no significant differences in astrogliosis were identified
between experimental groups; corresponding with previous results obtained in our lab.
Traditionally, astrocytes have been implicated as key regulators of neuroinflammation. During
stroke, observations of acute astrogliosis remain constant, as astrocytes function to encapsulate
the damaged region; initiating vital repair mechanisms 61,62. Presently, the specific involvement
of astrogliosis in chronic, stroke-induced secondary neuroinflammation, remains unknown.
Pathologically, astrogliosis has been associated with several CNS diseases

220–222

. However,

given the different origins and onsets of these injuries, the temporal and spatial changes of
reactive astrocytes have been known to vary, depending on the disease

221

. It is therefore

possible that while acute ischemic neuroinflammatory mechanisms predominately involve
astrogliosis, chronic secondary neuroinflammation, particularly within the white matter,
evokes alternative neuroinflammatory responses; primarily involving microglia.
4.5 Insular Ischemic Stroke and Remote Neurodegeneration
In our current rodent model, increased M1 microglia activation was observed in white
matter tracts 28 d following IC damage, displaying a chronic manifestation of white matter
injury. As mentioned previously, past experimental studies have identified WMI as a suitable
assay for axonal health; recognizing WMI as a histological correlate of axonal degeneration 92.
In accordance with these claims, our current observations of enhanced microglia activation
(WMI) within the corpus callosum and internal capsule of injured rats (IA/ET-1), would
insinuate a co-occurrence of chronic axonal damage.

71

Clinically, the pathological display of post-stroke white matter injury has become of
increased concern, largely due to the suspected role of axonal damage in secondary
neurodegeneration
the infarct zone

92

80–85

; an adverse outcome of stroke involving remote brain regions distal to

. Presently, the exact mechanisms of this delayed remote pathology are

unknown, and may vary depending on the affected structures

91

. Yet, an intriguing

commonality exists between all cases of stroke-induced secondary neurodegeneration: location
of the remote damage is dependent on anatomical connectivity to the primary infarct

87–91

,

supporting the likely involvement of white matter injury 92. Consequently, in observing WMI
after IC damage, a chronic display of remote secondary neurodegeneration was expected in
our injured rats (IA/ET-1). To affirm this anticipated outcome, total neuron counts were
measured in five forebrain regions anatomically connected to the IC: the PFC, ACC, amygdala,
hypothalamus and VP thalamus. Each of these areas were specifically chosen, due to their
autonomic involvement with IC regulation of cardiovascular function. Neurodegeneration in
any of these regions would provide valuable insight into the pathological manifestation of
autonomic dysfunction, and associated SIHI.
To our surprise, neuronal loss was not observed in any of the aforementioned forebrain
regions at 28 d post-insular injury, contradicting previous experimental findings. Past studies
involving MCAO in the rat, have consistently reported a delayed appearance of secondary
neurodegeneration in the thalamus 87,88,90,92. Adding to this, in a recent study by Weishaupt and
colleagues, chronic neurodegeneration and neuron cell death were observed in the retrosplenial
cortex of the rat 28 d following the bilateral injection of ET-1 into the PFC

91

. Consistently,

this data has confirmed the experimental existence of stroke-induced secondary
neurodegeneration, strongly opposing the results of our study. However, when analyzing this
prior data, it became evident that our study produced a substantially smaller infarct region;
suggesting a mechanistic impact of stroke severity on the initiation and/or perpetuation of
remote neurodegeneration. In our current model, limiting the infarct size was considered
necessary to produce a well-defined IC stroke, while the creation of a unilateral lesion allowed
for the evaluation of IC lateralization. Yet, it is possible that this unilateral infarct of small
volume may not be severe enough to produce previously described incidents of secondary
neurodegeneration, requiring a bilateral or larger site of damage.
To our knowledge, the correlative influence of stroke severity in remote
neurodegeneration has yet to be investigated. However, Iizuka and colleagues have reported
72

an enhanced prominence of terminal degeneration, within the corticothalamic fibers of rats
exhibiting a larger MCAO infarct

87

; supporting this proposed mechanistic interaction.

Recently, Weishaupt and colleagues published comparable findings to those outlined in this
thesis, discerning an absence of secondary neurodegeneration 28 d post-ischemic stroke

217

.

Similar to our study, this experiment produced a small infarct region, injecting 1 µL of ET-1
(10 pmol/µL), unilaterally, into the dorsomedial thalamus of the rat

217

. Interestingly, while

axonal degeneration occurred within connecting thalamocortical fibres, an accompanied
presence of secondary degeneration in remote grey matter regions was not observed

217

;

reaffirming our results.
In discussing this relationship of ischemic stroke and remote neurodegeneration, it is
important to note that increased M1 microglia activation was identified in the ipsilateral VP
thalamus of our injured rats (IA/ET-1), without the accompanying manifestation of neuronal
loss. It is therefore possible that, although the implied presence of axonal degeneration did not
correspond with the anticipated secondary neurodegeneration of remote brain regions; damage
to these white matter tracts parallels a chronic disruption of signal transduction. Secondary
activation of M1 microglia may necessitate pruning of faulty synapses, located in remote areas
like the VP thalamus, damaged as a result of this impaired axon function 218.
4.6 Insular Ischemic Stroke and Stroke-Induced Heart Injury
In 1989, Cechetto and colleagues were first to experimentally investigate ischemic
SIHI, recapitulating clinical observations of myocardial damage and dysfunction in a rodent
model of MCAO 55. Within this study, histological analysis of collected brain tissue revealed
an invariable inclusion of IC damage within the MCA ischemic zone 55. In seeing this, Cechetto
proposed a mechanistic influence of IC damage in SIHI, based upon the known role of IC
regulation in cardiovascular function. To date, various clinical and epidemiological studies
have discerned an association between IC damage and SIHI

7,124–127

; supporting Cechetto’s

hypothesis. Most recently, Gonzalez Toledo and colleagues identified IC damage in 30.4% of
ischemic stroke patients exhibiting atypical post-stroke ECGs; compared to a 7.3% prevalence
in patients with normal post-stroke cardiac function 7. As such, it was anticipated that the focal
induction of IC damage would evoke structural myocardial changes in our novel rodent model
of insular ischemic stroke.

73

At 28 d following IC injury, interstitial cardiac fibrosis was observed in the LA. To our
knowledge, this is the first reported observation of stroke-induced cardiac fibrosis; as previous
studies of SIHI have involved more acute timepoints

55,94,95,97,98,135,136

. During these prior

experiments, the structural manifestation of contraction band necrosis has consistently served
as a histological marker of myocardial cell death
hemorrhagic or ischemic stroke

223,224

2,93,105

, occurring within minutes of the

. Intriguingly, this pathology distinctly differs from

common observations of coagulative necrosis, seen after myocardial ischemia

225

; further

supporting a mechanistic variance between traditional heart disease and SIHI. Currently,
overactivation of the SNS, and accompanying NE toxicity, have been implicated as the cause
of contraction band necrosis

113,226,227

. Physiologically, NE is required for the regulated

opening of myocardial Ca2+ channels, responsible for cardiac muscle contraction

113

. If

prolonged, oversaturation of NE will stimulate cardiac muscle hypercontractivity, causing
irreversible cell death (contraction band necrosis)

2,93

. Overtime, this damaged myocardial

tissue will begin to remodel, likely giving rise to our chronic observations of cardiac fibrosis.
In this thesis, fibrosis of the LA was specifically analyzed, due to the contributing role
of LA dysfunction in AF 208,209. AF is a form of cardiac arrythmia known to increase the risk
of stroke 5-fold

15

; currently recognized as the most prevalent arrhythmia of SIHI

102

.

Clinically, these stroke-induced cases of AF have been described as brief and acute arrhythmic
episodes, associated with a low recurrence of ischemic stroke 228,229. However, with our recent
observations of cardiac fibrosis, a chronic development of AF, capable of more drastic
consequences, is certainly plausible. This local infiltration of fibrotic tissue can structurally
disrupt the subendocardium, altering the cardiac conduction system; contributing to the
generation of persistent AF

105

. Presently, it remains unknown whether the fibrotic changes

observed in our study are severe enough to cause AF, having only been observed in
approximately 5% of total LA area. Yet, in a clinical report by Hammermeister and
Reichenbach, minor foci of myocytolysis were deemed capable of initiating ECG
abnormalities 230; suggesting that less obvious cardiac lesions, like those detected in this study,
may be sufficient in producing detrimental changes to cardiac function. Experiments within
our lab are currently ongoing to assess the temporal progression of this fibrotic remodelling.
Similar to observed brain pathology, the hemispheric localization of IC damage did not
alter histological results; producing similar amounts of LA cardiac fibrosis after left or right
insular injury. Anatomically, the LA is surrounded by four pulmonary veins (PV), which
74

together, form the PV-LA junction; a heavily innervated autonomic area, densely populated by
both adrenergic (SNS) and cholinergic (PSNS) nerves 231. Intriguingly, these autonomic nerves
appear co-localized at both the tissue and cellular level, with a significant proportion (30%) of
cardiac ganglion cells displaying dual adrenocholinergic phenotypes

231

. As such, with this

lack of discrete PV-LA autonomic nerve predominance, an identical pathological display
would be expected; regardless the type of autonomic disturbance (sympathetic or
parasympathetic).
4.7 Inflammation and Stroke-Induced Heart Injury
The contribution of inflammation to the genesis and perpetuation of SIHI has gained
increased interest. As mentioned previously, neuroinflammation is a natural consequence of
ischemic stroke, known to disrupt the BBB

37,64,66

. Pathologically, this damage to the BBB

enables the release of local neuroinflammatory cytokines (TNFα, IL-1β) into the periphery;
inducing a systemic inflammatory response

37,66

. Intriguingly, persistent systemic

inflammation has been adversely linked to heart disease

187,188

inflammatory disease (sepsis, rheumatoid arthritis) patients

232–234

, as observed in chronic
. We therefore sought to

further explore the mechanistic influence of inflammation on SIHI, by correlating cerebral
inflammation to cardiac fibrosis.
As expected, increased microglia activation (neuroinflammation) correlated with the
enhanced presence of LA cardiac fibrosis; likely elicited through neuroinflammatory activation
of the systemic immune response. In the heart, including other internal organs, chronic
exposure to systemic inflammation can impair mitochondria function, resulting in the
unnatural accumulation of ROS

235,236

. Inevitably, this elicits a cascade of oxidative damage,

generating a local inflammatory response

235,236

. Interestingly, in the recent clinical study by

Westermann and colleagues, increased amounts of cardiac inflammatory cells positively
correlated with enhanced cardiac fibrosis and dysfunction, in heart failure patients

237

;

validating aforementioned mechanistic predictions. Currently, ongoing studies within our lab
are actively analyzing the local infiltration of immune cells (neutrophils, lymphocytes and
monocytes) into cardiac tissue, following IC injury. The future correlation of these results to
neuroinflammation and cardiac fibrosis, as well as the systemic measurement of
proinflammatory cytokines, are crucial in elucidating the pathophysiological impact of
inflammation on SIHI.
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Presently, it remains unclear whether this ischemic mechanism of inflammation is
independently capable of eliciting SIHI. Recently, Olshansky hypothesized a regulatory role
of the ANS in myocardial cytokine production; outlining parasympathetic involvement in the
attenuation of cardiac inflammation

114

. Furthermore, overstimulation of the SNS has been

implicated in the activation of a systemic, proinflammatory response

238

– insinuating an

autonomic influence over associated observations of inflammation post-insular injury. It is
therefore possible that, following stroke, ischemic-induced systemic inflammation perturbs
cardiac tissue, evoking the infiltration of inflammatory cells into the heart. Subsequently,
damage to the IC decreases parasympathetic tone, hindering the suppression of unwanted
inflammation. This, coupled with chronic exposure to SNS-induced systemic inflammation,
further exacerbates local cardiac inflammation; contributing to the observed presence of
cardiac fibrosis. In our current model, the ischemic induction of insular stroke presumably
causes both systemic inflammation (a direct result of the stroke) and autonomic dysfunction (a
direct result of IC damage); making it challenging to confirm an independent effect of
inflammation in SIHI. As such, future studies involving an alternative stroke location should
be performed, to examine whether stroke in this alternate region, not anatomically connected
to the IC, can produce similar levels of cardiac fibrosis as those produced in our current model.
4.8 Limitations and Future Directions
To date, the clinical investigation of SIHI has been challenging, due to the high
prevalence of shared risk factors between ischemic stroke and cardiovascular disorders

2,105

.

As such, we sought to establish a rodent model of focal insular ischemic stroke; capable of
progressing the pathophysiological understanding of SIHI, while simultaneously eliminating
these clinically-inevitable confounding variables. Experimental development of this novel
model has provided valuable insight into the neurological mechanisms of SIHI, confirming the
isolated involvement of IC stroke in the development of structural cardiac damage. However,
it is important to note that inception of this current rodent model does not exist without
limitations; many of which can be resolved in future studies.
Physiologically, substantial differences exist between males and females, contributing
to sex-specific alterations in the pathophysiological manifestation, progression and recovery
of illness and disease

239

. In stroke, current epidemiological data has delineated an increased

incidence in men, compared to women 240–242. Yet, women frequently present with more severe
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outcomes; linked to adverse mortality rates 240–242. To our knowledge, sex-related differences
in the underlying pathophysiology of SIHI have yet to be investigated, both clinically and
experimentally. Unfortunately, current results presented in this study do not address this
important, and often overlooked, phenomenon – having only used male rats. As such, future
experimental studies of SIHI should incorporate the use of female rodents, to examine the
likely effect of sex-specific differences involved in the mechanistic formation and perpetuation
of stroke-induced cardiac dysfunction.
In the present study, behavioural and pathological observations of IC damage were
restricted to the single timepoint of 28 d post-insular injury. However, it is possible that the
recovery of an acute pathological response may have already occurred prior to this chronic
period, resulting in the loss of key mechanistic information. Recently, Sposato and colleagues
reported an acute manifestation of stroke-induced cardiac arrhythmias, of which the majority
(approximately 75%) occurred within the first three days of stroke onset 229. Additionally, 2060% of ischemic stroke patients exhibit an acute elevation in serum cTnT, a known biomarker
of myocardial injury

104

. Interestingly, in a recent study by Wrigley and colleagues, this

increased presence of cTnT appeared to enhance the long-term risk for death after ischemic
stroke 104; implying the capable manifestation of acute SIHI into chronic, deadly outcomes. It
is therefore critical to include acute timepoints in future studies, as these early
pathophysiological changes may provide advanced mechanistic insight into the chronic
observations of SIHI detected in our current model.
Pathologically, results from this study do not take into consideration the potential
impact of infarct size on SIHI, or its underlying mechanisms. Yet, clinically, an association
between infarct volume and SIHI has been identified

229

. In a recent study by Sposato and

colleagues, 80% of patients diagnosed with stroke-induced AF displayed a large infarct volume
(>15 mm), recognizing infarct size as a predictor of SIHI 229. Based upon these results, Sposato
hypothesized that larger infarcts are associated with more severe autonomic dysregulation,
contributing to adverse outcomes of SIHI

229

. However, this has yet to be experimentally

proven. Future comparisons of SIHI outcomes using the current rodent model, and a MCAO
model, could enhance experimental understanding of this proposed mechanistic risk factor.
Lastly, in this newly developed model of focal insular ischemic stroke, a direct
assessment of cardiovascular autonomic function is absent; presenting an inherent mechanistic
limitation. Traditionally, HRV has served as a well-established tool used to assess cardiac
77

autonomic control, in both humans and animal models
requires the surgical implantation of a telemetric device

136,243,244
245

. In the conscious rat, this

. Due to the high costs associated

with animal telemetry, initial establishment of the present model was essential to confirm
proof-of-concept. As a next step, future studies should incorporate the use of telemetry into
this current insular stroke model. Analysis of HRV can verify the mechanistic role of
autonomic dysfunction in SIHI, further elucidating the pathophysiological underpinnings of
this complex brain-heart interaction.

In the present study, we confirmed, for the first time, the focal capability of IC ischemia
to generate SIHI; pathologically represented as the chronic manifestation of LA cardiac
fibrosis. At 28 d following IC injury, we identified remote microgliosis in the corpus callosum,
ipsilateral internal capsule and ipsilateral VP thalamus. Traditionally, this chronic display of
remote neuroinflammation has coincided with the secondary neurodegeneration of distal grey
matter regions 92. While the anticipated neurodegeneration of autonomic forebrain regions was
not observed in this study, significant microgliosis did occur at the internal capsule; likely
corresponding with the downstream manifestation of autonomic brainstem damage.
Supporting this notion, behavioural assessment of PPI displayed notable deficits following left
IC injury, indirectly demonstrating a possible functional impairment of autonomic activity.
Physiologically, the chronic presence of secondary neuroinflammation is also known to elicit
a prolonged, systemic immune response 64. Based upon the recent implication of inflammation
in myocardial fibrotic remodelling

114,187,188,210,211

, we correlated microgliosis to LA cardiac

fibrosis demonstrating, for the first time, a positive association between neuroinflammation
and SIHI. Taken together, these downstream observations of IC ischemia further support the
hypothesized mechanistic role, of both autonomic dysfunction and inflammation, in the
pathophysiological cascade of SIHI (Figure 25).
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Figure 25. Schematic summary outlining the proposed pathophysiological cascade of
stroke-induced heart injury.

79

Section 5: CONCLUSION
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The neurological influence of ischemic stroke in the generation of SIHI has been
acknowledged for several years. Yet, despite decades of research, the underlying
pathophysiology of this intricate brain-heart connection remains unknown. Clinically, it has
been hypothesized that stroke involving the IC initiates SIHI, since the IC controls autonomic
regulation of cardiovascular function

2,108,109

. However, given the high prevalence of shared

risk factors between ischemic stroke and cardiovascular disorders, current conclusions from
clinical studies are largely speculative

105

. We therefore sought to establish a novel rodent

model of focal insular ischemic stroke, vitally expanding current mechanistic knowledge of
SIHI.
Prior to this thesis, experimental studies of SIHI have exclusively involved animal
models of MCAO 55,135. However, use of this technique creates a large infarct region, extending
beyond the IC 55,56,120. Consequently, the isolated association of IC ischemia with SIHI has yet
to be confirmed. In the present study, use of ET-1 produced a focal, and much less severe,
ischemic infarct; limiting primary ischemia to the IC region. Pathologically, this confined
insular injury corresponded with the structural manifestation of LA cardiac fibrosis, supporting
the overarching hypothesis of focal IC involvement in SIHI development.
At 28 d following IC damage, rats subjected to left IC injury displayed an observable
trend of reduced PPI, demonstrating a potential lateralization of IC autonomic function.
Experimentally, this behavioural assessment of sensorimotor gating serves as a preliminary
hallmark of autonomic dysfunction; indirectly supporting the mechanistic association between
IC damage, autonomic impairment and SIHI. In correspondence with this behavioural
phenotype, an accompanying pathology of secondary microgliosis was observed in the corpus
callosum, ipsilateral internal capsule and ipsilateral VP thalamus, 28 d following IC ischemia.
Traditionally, this chronic display of remote neuroinflammation has coincided with the
secondary neurodegeneration of distal grey matter regions 92. As such, secondary neuronal loss,
within remote forebrain regions of IC autonomic circuitry, was expected. Yet, upon
histological examination, this anticipated chronic display of secondary neurodegeneration was
not observed. However, significant microgliosis did occur in the ipsilateral internal capsule of
injured rats; likely corresponding with a downstream manifestation of autonomic brainstem
damage. Consequently, future analysis of brainstem pathology, as well as the telemetric

81

analysis of HRV, should be performed to directly affirm the mechanistic role of autonomic
cardiovascular dysfunction in SIHI.
In addition to autonomic dysfunction, inflammation has been implicated as a cause of
SIHI, known to induce myocardial fibrotic remodelling 114,187,188,210,211. To further examine this
potential pathophysiological relationship, we correlated microgliosis of the corpus callosum,
ipsilateral internal capsule and ipsilateral VP thalamus, to LA cardiac fibrosis. At 28 d
following IC injury, increased microgliosis consistently associated with the enhanced
presentation of LA fibrosis; demonstrating a positive correlative relationship between these
two variables. Presently, it remains unclear whether this ischemic mechanism of inflammation
is independently capable of eliciting SIHI. Recently, Olshansky hypothesized a regulatory role
of the ANS in myocardial cytokine production, outlining a parasympathetic role of cardiac
inflammation attenuation 114. Furthermore, overstimulation of the SNS has been implicated in
the activation of a systemic, proinflammatory response

238

. It is therefore possible that,

following stroke, ischemic-induced systemic inflammation perturbs cardiac tissue, evoking the
infiltration of inflammatory cells into the heart. Subsequently, damage to the IC decreases
parasympathetic tone, hindering the suppression of unwanted inflammation. This, coupled with
chronic exposure to SNS-induced systemic inflammation, further exacerbates local cardiac
inflammation; contributing to the observed presence of cardiac fibrosis. As such, SIHI is likely
the synergistic result of both autonomic dysfunction and inflammation, arising from the clinical
occurrence of insular ischemic stroke.
To date, establishment of this insular ischemic stroke model has only just begun to
scratch the complex, and compelling, mechanistic surface of SIHI. Currently, primary use of
this novel model has recapitulated the clinical manifestation of SIHI after IC ischemia; creating
a reliable experimental mold for the future investigation of this intricate disease. Presently,
post-stroke cardiovascular complications remain a prominent cause of death

105

. Yet, aside

from the management of associated vascular risk factors, a tailored clinical plan for the
specialized treatment of SIHI does not exist

105

. Future use of this model will only enhance

mechanistic understanding of SIHI, ultimately leading to the vital development of novel
therapies capable of preventing these adverse cardiovascular outcomes of ischemic stroke.
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